C.12.02 The interaction between the internal clock and antidepressant efficacy (Englisch)
- Neue Suche nach: Racagni, G.
- Neue Suche nach: Racagni, G.
In:
EUROPEAN NEUROPSYCHOPHARMACOLOGY
;
17
;
S605
;
2007
-
ISSN:
- Aufsatz (Zeitschrift) / Print
-
Titel:C.12.02 The interaction between the internal clock and antidepressant efficacy
-
Beteiligte:Racagni, G. ( Autor:in )
-
Erschienen in:EUROPEAN NEUROPSYCHOPHARMACOLOGY ; 17 ; S605
-
Verlag:
- Neue Suche nach: Elsevier Science B.V., Amsterdam.
-
Erscheinungsdatum:01.01.2007
-
Format / Umfang:S605
-
ISSN:
-
Medientyp:Aufsatz (Zeitschrift)
-
Format:Print
-
Sprache:Englisch
- Neue Suche nach: 616.8 / 615.1
- Weitere Informationen zu Dewey Decimal Classification
-
Klassifikation:
-
Datenquelle:
© Metadata Copyright the British Library Board and other contributors. All rights reserved.
Inhaltsverzeichnis – Band 17
Zeige alle Jahrgänge und Ausgaben
Die Inhaltsverzeichnisse werden automatisch erzeugt und basieren auf den im Index des TIB-Portals verfügbaren Einzelnachweisen der enthaltenen Beiträge. Die Anzeige der Inhaltsverzeichnisse kann daher unvollständig oder lückenhaft sein.
- 1
-
Social isolation stress and neuroactive steroidsSerra, M. / Sanna, E. / Mostallino, M. C. / Biggio, G. et al. | 2007
- 12
-
CSF monoamine metabolites and lethality of suicide attempts in depressed patients with alcohol dependenceSher, L. / Oquendo, M. A. / Grunebaum, M. F. / Burke, A. K. / Huang, Y. y. / Mann, J. J. et al. | 2007
- 16
-
Spatial working memory in obsessive–compulsive disorder improves with clinical response: A functional MRI studyvan der Wee, N. J. / Ramsey, N. F. / van Megen, H. J. / Denys, D. / Westenberg, H. G. / Kahn, R. S. et al. | 2007
- 24
-
GABAA receptors of hippocampal CA1 regions are involved in the acquisition and expression of morphine-induced place preferenceRezayof, A. / Razavi, S. / Haeri-Rohani, A. / Rassouli, Y. / Zarrindast, M. R. et al. | 2007
- 32
-
A meta-analysis of clinical trials comparing milnacipran, a serotonin–norepinephrine reuptake inhibitor, with a selective serotonin reuptake inhibitor for the treatment of major depressive disorderPapakostas, G. I. / Fava, M. et al. | 2007
- 37
-
Effects of neurosteroids on glucocorticoid receptor-mediated gene transcription in LMCAT cells—A possible interaction with psychotropic drugsBasta-Kaim, A. / Budziszewska, B. a. / Jaworska-Feil, L. / Leśkiewicz, M. / Tetich, M. / Otczyk, M. / Kubera, M. / Lasoń, W. a. et al. | 2007
- 46
-
Dopamine transporters and cognitive function in methamphetamine abuser after a short abstinence: A SPECT studyChou, Y. H. / Huang, W. S. / Su, T. P. / Lu, R. B. / Wan, F. J. / Fu, Y. K. et al. | 2007
- 53
-
Exogenously administered d-serine failed to potentiate the ability of MK-801 to antagonize electrically precipitated seizures in nonhandled control and stressed miceLong, K. D. / Mastropaolo, J. / Rosse, R. B. / Deutsch, S. I. et al. | 2007
- 58
-
Psychological and cytokine changes in children and adolescents undergoing hematopoietic stem cell transplantationMunitz-Shenkar, D. / Krulik, T. / Peretz, C. / Shiloh, R. / Elhasid, R. / Toren, A. / Weizman, A. et al. | 2007
- 64
-
Galanin enhances and a galanin antagonist attenuates depression-like behaviour in the ratKuteeva, E. / Wardi, T. / Hökfelt, T. / Ögren, S. O. et al. | 2007
- 70
-
ECNP consensus meeting. Negative, depressive and cognitive symptoms of schizophrenia. Nice, March 2004Montgomery, S. A. / van Zwieten-Boot, B. et al. | 2007
- 78
-
Calendar| 2007
- 79
-
Antipsychotic augmentation of serotonergic antidepressants in treatment-resistant obsessive–compulsive disorder: A meta-analysis of the randomized controlled trialsSkapinakis, P. / Papatheodorou, T. / Mavreas, V. et al. | 2007
- 94
-
Isobolographic analysis of interactions between losigamone and conventional antiepileptic drugs in the mouse maximal electroshock modelBorowicz, K. K. / Kimber-Trojnar, Z. / Ratnaraj, N. / Patsalos, P. N. / Luszczki, J. J. / Czuczwar, S. J. et al. | 2007
- 102
-
Striatal D2 receptor occupancy in bipolar patients treated with olanzapineAttarbaschi, T. / Sacher, J. / Geiss-Granadia, T. / Klein, N. / Mossaheb, N. / Lanzenberger, R. / Asenbaum, S. / Dudczak, R. / Kasper, S. / Tauscher, J. et al. | 2007
- 108
-
The progesterone metabolite allopregnanolone potentiates GABAA receptor-mediated inhibition of 5-HT neuronal activityKaura, V. / Ingram, C. D. / Gartside, S. E. / Young, A. H. / Judge, S. J. et al. | 2007
- 116
-
Membrane fatty acids, reading and spelling in dyslexic and non-dyslexic adultsCyhlarova, E. / Bell, J. G. / Dick, J. R. / MacKinlay, E. E. / Stein, J. F. / Richardson, A. J. et al. | 2007
- 122
-
Modification of formalin-induced nociception by different histamine receptor agonists and antagonistsFarzin, D. / Nosrati, F. et al. | 2007
- 129
-
Desensitization of 5-HT1A autoreceptors induced by neonatal DSP-4 treatmentDąbrowska, J. / Nowak, P. a. / Brus, R. et al. | 2007
- 138
-
Long-term safety and tolerability of long-acting injectable risperidone in patients with schizophrenia or schizoaffective disorderLindenmayer, J. P. / Khan, A. / Eerdekens, M. l. / Van Hove, I. / Kushner, S. et al. | 2007
- 145
-
Impaired attention is central to the cognitive deficits observed in alpha 7 deficient miceYoung, J. W. / Crawford, N. / Kelly, J. S. / Kerr, L. E. / Marston, H. M. / Spratt, C. / Finlayson, K. / Sharkey, J. et al. | 2007
- 156
-
Calendar of Events| 2007
- 157
-
Neurosteroids in child and adolescent psychopathologyGolubchik, P. / Lewis, M. / Maayan, R. / Sever, J. / Strous, R. / Weizman, A. et al. | 2007
- 165
-
Treating dopamimetic psychosis in Parkinson's disease: Structured review and meta-analysisFrieling, H. / Hillemacher, T. / Ziegenbein, M. / Neundörfer, B. / Bleich, S. et al. | 2007
- 172
-
Antidepressant-like effects of mGluR1 and mGluR5 antagonists in the rat forced swim and the mouse tail suspension testsBelozertseva, I. V. / Kos, T. / Popik, P. / Danysz, W. / Bespalov, A. Y. et al. | 2007
- 180
-
The effect of chronic peripubertal cannabinoid treatment on deficient object recognition memory in rats after neonatal mPFC lesionSchneider, M. / Koch, M. et al. | 2007
- 187
-
Effect of antidepressant drugs on 6-OHDA-treated mice in the FSTChenu, F. / Dailly, E. / Bourin, M. et al. | 2007
- 194
-
Serum creatine kinase level in unmedicated nonpsychotic, psychotic, bipolar and schizoaffective depressed patientsSegal, M. / Avital, A. / Drobot, M. / Lukanin, A. / Derevenski, A. / Sandbank, S. / Weizman, A. et al. | 2007
- 199
-
Difference in susceptibility to activity-based anorexia in two inbred strains of miceGelegen, C. / Collier, D. A. / Campbell, I. C. / Oppelaar, H. / van den Heuvel, J. / Adan, R. A. / Kas, M. J. et al. | 2007
- 206
-
Amphetamine induced rotation in the assessment of lesions and grafts in the unilateral rat model of Parkinson's diseaseTorres, E. M. / Dunnett, S. B. et al. | 2007
- 215
-
The role of noradrenergic tone in the dorsal raphe nucleus of the mouse in the acute behavioral effects of antidepressant drugsO'Leary, O. F. / Bechtholt, A. J. / Crowley, J. J. / Valentino, R. J. / Lucki, I. et al. | 2007
- 227
-
Comparative efficacy of liposome-entrapped amiloride and free amiloride in animal models of seizures and serum potassium in miceAli, A. / Kolappa Pillai, K. / Jalees Ahmad, F. / Dua, Y. / Iqbal Khan, Z. / Vohora, D. et al. | 2007
- 230
-
Association of the serotonin transporter promotor polymorphism with suicide attempters with a high medical damageWasserman, D. / Geijer, T. / Sokolowski, M. / Frisch, A. / Michaelovsky, E. / Weizman, A. / Rozanov, V. / Wasserman, J. et al. | 2007
- 235
-
Three-year antipsychotic effectiveness in the outpatient care of schizophrenia: Observational versus randomized studies resultsHaro, J. M. / Suarez, D. / Novick, D. / Brown, J. / Usall, J. / Naber, D. et al. | 2007
- 245
-
Juvenile stress induces a predisposition to either anxiety or depressive-like symptoms following stress in adulthoodTsoory, M. / Cohen, H. / Richter-Levin, G. et al. | 2007
- 257
-
State and trait related predictors of serum cortisol to DHEA(S) molar ratios and hormone concentrations in schizophrenia patientsRitsner, M. / Gibel, A. / Maayan, R. / Ratner, Y. / Ram, E. / Modai, I. / Weizman, A. et al. | 2007
- 265
-
Interactions between zonisamide and conventional antiepileptic drugs in the mouse maximal electroshock test modelBorowicz, K. K. / Luszczki, J. J. / Sobieszek, G. / Ratnaraj, N. / Patsalos, P. N. / Czuczwar, S. c. et al. | 2007
- 273
-
CLOCK gene T3111C polymorphism is associated with Japanese schizophrenics: A preliminary studyTakao, T. / Tachikawa, H. / Kawanishi, Y. / Mizukami, K. / Asada, T. et al. | 2007
- 277
-
Effects of the novel 5-HT6 receptor antagonist RO4368554 in rat models for cognition and sensorimotor gatingSchreiber, R. / Vivian, J. / Hedley, L. / Szczepanski, K. / Secchi, R. L. / Zuzow, M. / van Laarhoven, S. / Moreau, J. L. / Martin, J. R. / Sik, A. et al. | 2007
- 289
-
Effects of frequent cannabis use on hippocampal activity during an associative memory taskJager, G. / Van Hell, H. H. / De Win, M. M. / Kahn, R. S. / Van Den Brink, W. / Van Ree, J. M. / Ramsey, N. F. et al. | 2007
- 298
-
Electroconvulsive stimuli selectively affect behavior and neuropeptide Y (NPY) and NPY Y1 receptor gene expressions in hippocampus and hypothalamus of Flinders Sensitive Line rat model of depressionJiménez-Vasquez, P. A. / Diaz-Cabiale, Z. / Caberlotto, L. / Bellido, I. / Overstreet, D. / Fuxe, K. / Mathé, A. A. et al. | 2007
- 309
-
Non-steroidal anti-inflammatory drugs and the risk of psychosisLaan, W. / Selten, J. P. / Grobbee, D. E. / Smeets, H. / Kahn, R. S. / Burger, H. et al. | 2007
- 313
-
Impulsivity and bipolar disorderNajt, P. / Perez, J. / Sanches, M. / Peluso, M. A. / Glahn, D. / Soares, J. C. et al. | 2007
- 321
-
Genetics and personality traits in patients with social anxiety disorder: A case-control study in South AfricaLochner, C. / Hemmings, S. / Seedat, S. / Kinnear, C. / Schoeman, R. / Annerbrink, K. / Olsson, M. / Eriksson, E. / Moolman-Smook, J. / Allgulander, C. et al. | 2007
- 328
-
Neurokinin 1 receptor antagonism requires norepinephrine to increase serotonin functionGobbi, G. / Cassano, T. / Radja, F. / Morgese, M. G. / Cuomo, V. / Santarelli, L. / Hen, R. / Blier, P. et al. | 2007
- 339
-
Why do young women smoke? III. Attention and impulsivity as neurocognitive predisposing factorsYakir, A. / Rigbi, A. / Kanyas, K. / Pollak, Y. / Kahana, G. / Karni, O. / Eitan, R. / Kertzman, S. / Lerer, B. et al. | 2007
- 352
-
Amphetamine pretreatment accelerates the subsequent escalation of cocaine self-administration behaviorFerrario, C. R. / Robinson, T. E. et al. | 2007
- 358
-
Differences in blood pregnenolone and dehydroepiandrosterone levels between schizophrenia patients and healthy subjectsRitsner, M. / Maayan, R. / Gibel, A. / Weizman, A. et al. | 2007
- 366
-
Effects of constitutive deletion of opioid receptors on the basal densities of Fas and Fas-associated protein with death domain (FADD) in the mouse brain: A δ-opioid tone inhibits FADDGarcía-Fuster, M. J. / Ferrer-Alcón, M. / Martín, M. / Kieffer, B. L. / Maldonado, R. / García-Sevilla, J. s. et al. | 2007
- 375
-
Thioperamide reduces intracellular calcium in mouse brain synaptosomesVohora, D. / Pal, S. N. / Pillai, K. K. et al. | 2007
- 377
-
Drug addiction: Pathways to the disease and pathophysiological perspectivesLe Moal, M. / Koob, G. F. et al. | 2007
- 394
-
Signs of a higher prevalence of autoimmune thyroiditis in female offspring of bipolar parentsHillegers, M. H. / Reichart, C. G. / Wals, M. / Verhulst, F. C. / Ormel, J. / Nolen, W. A. / Drexhage, H. A. et al. | 2007
- 400
-
Response to SSRIs and role of the hormonal therapy in post-menopausal depressionZanardi, R. / Rossini, D. / Magri, L. / Malaguti, A. / Colombo, C. / Smeraldi, E. et al. | 2007
- 406
-
Association study between the dopamine receptor D4 gene and obsessive-compulsive disorderCamarena, B. / Loyzaga, C. / Aguilar, A. / Weissbecker, K. / Nicolini, H. et al. | 2007
- 410
-
ABCG1 gene variants in suicidal behavior and aggression-related traitsGietl, A. / Giegling, I. / Hartmann, A. M. / Schneider, B. / Schnabel, A. / Maurer, K. / Möller, H. J. / Rujescu, D. et al. | 2007
- 417
-
Effect of chronic citalopram on serotonin-related and stress-regulated genes in the dorsal raphe nucleus of the ratAbumaria, N. / Rygula, R. / Hiemke, C. / Fuchs, E. / Havemann-Reinecke, U. / Rüther, E. / Flügge, G. et al. | 2007
- 430
-
Escitalopram prevents relapse of obsessive-compulsive disorderFineberg, N. A. / Tonnoir, B. / Lemming, O. / Stein, D. J. et al. | 2007
- 440
-
Omega-3 fatty acid monotherapy for pediatric bipolar disorder: A prospective open-label trialWozniak, J. / Biederman, J. / Mick, E. / Waxmonsky, J. / Hantsoo, L. / Best, C. / Cluette-Brown, J. E. / Laposata, M. et al. | 2007
- 448
-
Effects of risperidone on dopamine receptor subtypes in developing rat brainMoran-Gates, T. / Grady, C. / Shik Park, Y. / Baldessarini, R. J. / Tarazi, F. I. et al. | 2007
- 456
-
A 6-month prospective, observational, naturalistic, uncontrolled study to evaluate the effectiveness and tolerability of oral ziprasidone in patients with schizophreniaArango, C. / Gómez-Beneyto, M. / Brenlla, J. / Gastó, C. / Sarramea-Crespo, F. / Chamorro, L. / Masramon, X. / Díez, T. et al. | 2007
- 464
-
Long-lasting behavioral effects of juvenile trauma in an animal model of PTSD associated with a failure of the autonomic nervous system to recoverCohen, H. / Kaplan, Z. / Matar, M. A. / Loewenthal, U. / Zohar, J. / Richter-Levin, G. et al. | 2007
- 478
-
A significant correlation between ward temperature and the severity of symptoms in schizophrenia inpatients — A longitudinal studyShiloh, R. / Munitz, H. / Stryjer, R. / Weizman, A. et al. | 2007
- 483
-
Effect of GABAergic ligands on the anxiolytic-like activity of DOI (a 5-HT2A/2C agonist) in the four-plate test in miceMassé, F. / Hascoët, M. / Bourin, M. et al. | 2007
- 492
-
Effects of acute antipsychotic treatment on brain activation in first episode psychosis: An fMRI studyFusar-Poli, P. / Broome, M. R. / Matthiasson, P. / Williams, S. C. / Brammer, M. / McGuire, P. K. et al. | 2007
- 501
-
Additional support for linkage of schizophrenia and bipolar disorder to chromosome 3q29Schosser, A. / Fuchs, K. / Scharl, T. / Leisch, F. / Bailer, U. / Kasper, S. / Sieghart, W. / Hornik, K. / Aschauer, H. N. et al. | 2007
- 506
-
Contents Continued| 2007
- 507
-
Stereoselective neuroimaging in vivoSmith, D. F. / Jakobsen, S. et al. | 2007
- 523
-
Reduced platelet vesicular monoamine transporter density in Tourette's syndrome pediatric male patientsBen-Dor, D. H. / Zimmerman, S. / Sever, J. / Roz, N. / Apter, A. / Rehavi, M. / Weizman, A. et al. | 2007
- 527
-
Duloxetine increases stage 3 sleep and suppresses rapid eye movement (REM) sleep in patients with major depressionKluge, M. / Schüssler, P. / Steiger, A. et al. | 2007
- 532
-
Augmented reinforcer value and accelerated habit formation after repeated amphetamine treatmentNordquist, R. E. / Voorn, P. / de Mooij-van Malsen, J. G. / Joosten, R. N. / Pennartz, C. M. / Vanderschuren, L. J. et al. | 2007
- 541
-
Circulatory neurosteroid levels in smoking and non-smoking chronic schizophrenia patientsIancu, I. / Tchernihovsky, E. / Maayan, R. / Poreh, A. / Dannon, P. / Kotler, M. / Weizman, A. / Strous, R. D. et al. | 2007
- 546
-
Chronic antidepressant treatment induces contrasting patterns of synaptophysin and PSA-NCAM expression in different regions of the adult rat telencephalonVarea, E. / Castillo-Gómez, E. / Gómez-Climent, M. A. / Blasco-Ibáñez, J. M. / Crespo, C. / Martínez-Guijarro, F. J. / Nàcher, J. et al. | 2007
- 558
-
The effect of naltrexone and acamprosate on cue-induced craving, autonomic nervous system and neuroendocrine reactions to alcohol-related cues in alcoholicsOoteman, W. / Koeter, M. W. / Verheul, R. / Schippers, G. M. / van den Brink, W. et al. | 2007
- 567
-
Reviewing the role of the genes G72 and DAAO in glutamate neurotransmission in schizophreniaBoks, M. P. / Rietkerk, T. / van de Beek, M. H. / Sommer, I. E. / de Koning, T. J. / Kahn, R. S. et al. | 2007
- 573
-
Reduced orexin levels in the cerebrospinal fluid of suicidal patients with major depressive disorderBrundin, L. / Björkqvist, M. / Petersén, s. / Träskman-Bendz, L. et al. | 2007
- 580
-
Effects of the 5-HT1B receptor antagonist NAS-181 on extracellular levels of acetylcholine, glutamate and GABA in the frontal cortex and ventral hippocampus of awake rats: A microdialysis studyHu, X. J. / Wang, F. H. / Stenfors, C. / Ögren, S. O. / Kehr, J. et al. | 2007
- 587
-
How do genes exert their role? Period 3 gene variants and possible influences on mood disorder phenotypesArtioli, P. / Lorenzi, C. / Pirovano, A. / Serretti, A. / Benedetti, F. / Catalano, M. / Smeraldi, E. et al. | 2007
- 595
-
NO synthase-positive striatal interneurons are decreased in schizophreniaFritzen, S. / Lauer, M. / Schmitt, A. / Töpner, T. / Strobel, A. / Lesch, K. P. / Reif, A. et al. | 2007
- 600
-
Involvement of IL-1β in acute stress-induced worsening of cerebral ischaemia in ratsCaso, J. R. / Moro, M. a. / Lorenzo, P. / Lizasoain, I. / Leza, J. C. et al. | 2007
- 608
-
Positron emission tomography study of regional brain metabolic responses to a serotonergic challenge in major depressive disorder with and without comorbid lifetime alcohol dependenceSher, L. / Milak, M. S. / Parsey, R. V. / Carballo, J. J. / Cooper, T. B. / Malone, K. M. / Oquendo, M. A. / Mann, J. J. et al. | 2007
- 616
-
Subsequent exposure to the choline uptake enhancer MKC-231 antagonizes phencyclidine-induced behavioral deficits and reduction in septal cholinergic neurons in ratsShirayama, Y. / Yamamoto, A. / Nishimura, T. / Katayama, S. / Kawahara, R. et al. | 2007
- 627
-
Role of acetaldehyde in tobacco smoke addictionTalhout, R. / Opperhuizen, A. / van Amsterdam, J. G. et al. | 2007
- 637
-
Behavioural effects of rapid intravenous administration of meta-chlorophenylpiperazine (m-CPP) in patients with generalized social anxiety disorder, panic disorder and healthy controlsVan Veen, J. F. / Van der Wee, N. J. / Fiselier, J. / Van Vliet, I. M. / Westenberg, H. G. et al. | 2007
- 643
-
Synergistic effects of tandospirone and selective serotonin reuptake inhibitors on the contextual conditioned fear stress response in ratsNishikawa, H. / Inoue, T. / Izumi, T. / Koyama, T. et al. | 2007
- 651
-
Role of serotonergic gene polymorphisms on response to transcranial magnetic stimulation in depressionZanardi, R. / Magri, L. / Rossini, D. / Malaguti, A. / Giordani, S. / Lorenzi, C. / Pirovano, A. / Smeraldi, E. / Lucca, A. et al. | 2007
- 658
-
Differential effects of adjunctive methylphenidate and citalopram on extracellular levels of serotonin, noradrenaline and dopamine in the rat brainWeikop, P. / Yoshitake, T. / Kehr, J. et al. | 2007
- 672
-
The effect of doxapram on brain imaging in patients with panic disorderGarakani, A. / Buchsbaum, M. S. / Newmark, R. E. / Goodman, C. / Aaronson, C. J. / Martinez, J. M. / Torosjan, Y. / Chu, K. W. / Gorman, J. M. et al. | 2007
- 687
-
Current issues in bipolar disorder: A critical reviewOswald, P. / Souery, D. / Kasper, S. / Lecrubier, Y. / Montgomery, S. / Wyckaert, S. / Zohar, J. / Mendlewicz, J. et al. | 2007
- 696
-
What is the meaning of treatment resistant/refractory major depression (TRD)? A systematic review of current randomized trialsBerlim, M. T. / Turecki, G. et al. | 2007
- 708
-
Novel sigma (σ) receptor agonists produce antidepressant-like effects in miceWang, J. / Mack, A. L. / Coop, A. / Matsumoto, R. R. et al. | 2007
- 717
-
Serotonergic mechanisms in the basolateral amygdala differentially regulate the conditioned and unconditioned fear organized in the periaqueductal grayMartinez, R. C. / Ribeiro de Oliveira, A. / Brandão, M. L. et al. | 2007
- 725
-
Effect of olanzapine or risperidone treatment on some cognitive functions in a one-year follow-up of schizophrenia outpatients with prominent negative symptomsGurpegui, M. / Bousoño, M. / Ciudad, A. / Carlos Gómez, J. / Olivares, J. M. et al. | 2007
- 735
-
Repeated paroxetine treatment reverses anhedonia induced in rats by chronic mild stress or dexamethasoneCasarotto, P. C. / Andreatini, R. et al. | 2007
- 743
-
Limitations of current medical treatments for depression: Disturbed circadian rhythms as a possible therapeutic targetLader, M. et al. | 2007
- 756
-
Chronic amphetamine treatment reduces NGF and BDNF in the rat brainAngelucci, F. / Gruber, S. H. / El Khoury, A. / Tonali, P. A. / Mathé, A. A. et al. | 2007
- 763
-
CK levels in unmedicated bipolar patientsSegal, M. / Avital, A. / Drobot, M. / Lukanin, A. / Derevenski, A. / Sandbank, S. / Weizman, A. et al. | 2007
- 768
-
Differential effects of classical and atypical antipsychotic drugs on rotenone-induced neurotoxicity in PC12 cellsTan, Q. R. / Wang, X. Z. / Wang, C. Y. / Liu, X. J. / Chen, Y. C. / Wang, H. H. / Zhang, R. G. / Zhen, X. C. / Tong, Y. / Zhang, Z. J. et al. | 2007
- 774
-
Immunomodulatory effect of selective serotonin reuptake inhibitors (SSRIs) on human T lymphocyte function and gene expressionTaler, M. / Gil-Ad, I. / Lomnitski, L. / Korov, I. / Baharav, E. / Bar, M. / Zolokov, A. / Weizman, A. et al. | 2007
- 781
-
Comparing and combining gamma-hydroxybutyric acid (GHB) and naltrexone in maintaining abstinence from alcohol: An open randomised comparative studyCaputo, F. / Addolorato, G. / Stoppo, M. / Francini, S. / Vignoli, T. / Lorenzini, F. / Del Re, A. / Comaschi, C. / Andreone, P. / Trevisani, F. et al. | 2007
- 790
-
Agmatine inhibits morphine-induced locomotion sensitization and morphine-induced changes in striatal dopamine and metabolites in ratsWei, X. L. / Su, R. B. / Wu, N. / Lu, X. Q. / Zheng, J. Q. / Li, J. et al. | 2007
- S101
-
Risk factors for schizophrenia — All roads lead to dopamineDi Forti, M. / Lappin, J. M. / Murray, R. M. et al. | 2007
- S108
-
Management of agitation in the acute psychotic patient — Efficacy without excessive sedationCañas, F. et al. | 2007
- S115
-
The stable patient with schizophrenia — From antipsychotic effectiveness to adherenceThomas, P. et al. | 2007
- S123
-
The long term — Maximising potential for rehabilitation in patients with schizophreniaFagiolini, A. / Goracci, A. et al. | 2007
- S168
-
The acute effects of modafinil on mood, self-assessment, driving simulator performance, and neuropsychological performance following sleep deprivationGurtman, C. / Broadbear, J. / Redman, J. et al. | 2007
- S173
-
PL.03 The schizophrenia paradigm: a hundred-year challengeCarpenter, W. T. et al. | 2007
- S175
-
S.01.03 Neurocognition and neuroimaging in children with conduct disorderBlair, R. / Finger, E. / Marsh, A. et al. | 2007
- S176
-
S.02.01 Significance of depressive subtypesMoller, H. J. et al. | 2007
- S177
-
S.02.04 Glutamate modulators in treatment resistant depressionZarate, C. et al. | 2007
- S178
-
S.03.02 The role of the hippocampus in visuospatial and episodic memory: animal and human modelsBurgess, N. / Doeller, C. D. / Barry, C. / Jeffery, K. J. et al. | 2007
- S180
-
S.04.03 Neuron and forebrain specific deletion of the glycine transporter 1 gene enhances spontaneous object recognition memorySinger, P. / Boison, D. / Mohler, H. / Feldon, J. / Yee, B. K. et al. | 2007
- S181
-
S.04.06 Assessing the genetic influence on anxiety behaviour and stress-induced brain activation in the mouseO Mahony, C. M. / Sweeney, F. / Daly, E. / Dinan, T. G. / Cryan, J. F. et al. | 2007
- S182
-
S.05.0l Varenicline and rimonabant in tobacco dependence - promises and weaknessBerlin, I. et al. | 2007
- S183
-
S.06.01 Non-cognitive and behavioural symptoms in Alzheimers diseaseDal Forno, G. et al. | 2007
- S185
-
S.07.02 The effect of acute exercise on hippocampal based learning and serum growth factor concentration in sedentary young menGriffin, E. / Foley, C. / Mullally, S. / OMara, S. / Kelly, A. et al. | 2007
- S186
-
S.07.05 Prednisolone suppression test as a predictor of outcome in treatment resistant depressionJuruena, M. F. / Cleare, A. J. / Papadopoulos, A. S. / Poon, L. / Lightman, S. L. / Pariante, C. M. et al. | 2007
- S187
-
S.07.07 Increased opioid receptor binding in early abstinence from dependent opioid and alcohol use and relationship to cravingWilliams, T. M. / Lingford-Hughes, A. / Davies, S. J. / Daglish, M. R. / Taylor, L. G. / Hammers, A. / Brooks, D. J. / Grasby, P. / Myles, J. S. / Nutt, D. J. et al. | 2007
- S188
-
S.08.02 Animal models for the assessment of cognitive dysfunctions in schizophrenia: focus on the nitric oxide pathwayKlamer, D. S. / Palsson, E. N. / Wass, C. E. / Fejgin, K. W. / Finnerty, N. J. / Lowry, J. P. / Engel, J. A. / Svensson, L. I. et al. | 2007
- S189
-
S.08.04 The nitric oxide pathway in anxiety and stress-related disordersWegener, G. / Vistisen, A. K. / Nielsen, S. R. / Volke, V. / Harvey, B. H. et al. | 2007
- S190
-
S.09.02 Lithium and traditional anticonvulsants: still useful?Rybakowski, J. et al. | 2007
- S192
-
S.10.03 Computerized training of working memory in children with ADHDKlingberg, T. et al. | 2007
- S193
-
S.11.01 Repeated social defeat-induced anxiety-like behavioural and neurobiological alterations in ratsBenoliel, J. / Zeau, B. / Rivat, C. / Blugeot, A. / Becker, C. et al. | 2007
- S194
-
S.11.04 Neurobiological correlates to PTSDVermetten, E. et al. | 2007
- S195
-
S.14.01 Frontal dopamine D2-receptor binding potentials in drug-naive first-episode schizophrenic patients predict the effect of antipsychotic treatmentGlenthoj, B. Y. / Rasmussen, H. / Mackeprang, T. / Svarer, C. / Pinborg, L. / Friberg, L. / Videbaek, C. et al. | 2007
- S196
-
S.14.05 The Edinburgh high risk studyJohnstone, E. / Ebmeier, K. P. / Miller, P. / Lawrie, S. M. / Owens, D. G. et al. | 2007
- S198
-
S.15.05 Molecular mechanisms of GR sensitivity in vitro and in vivoPariante, C. et al. | 2007
- S199
-
S.16.03 Nicotinic modulation of dopaminergic neurons: upstream and downstream targets of nicotine addictionMansvelder, H. D. / Couey, J. J. et al. | 2007
- S201
-
S.17.04 Side effects of antipsychotic polypharmacyDrago, F. / Caraci, F. et al. | 2007
- S202
-
S.18.02 Cannabis effects on brain function and structure of adolescents and young adultsBlock, R. I. / OLeary, D. S. / Jager, G. / Zuccarelli, J. M. / Becker, M. M. / Luijten, M. / Ramsey, N. F. et al. | 2007
- S204
-
S.19.02 Sporadic and familial cerebral amyloid angiopathiesRevesz, T. et al. | 2007
- S205
-
S.19.05 Paradigm shift in Alzheimers disease: intraneuronal Ab aggregation triggers neuron lossBayer, T. A. / Breyhan, H. / Duan, K. / Rettig, J. / Wirths, O. et al. | 2007
- S206
-
S.20.03 Galanin receptor agonists and antagonists as potential novel antidepressantsOgren, S. O. / Kuteeva, E. / Wardi, T. / Hokfelt, T. et al. | 2007
- S207
-
S.21.01 Treatment-resistant panic anxiety disorderBandelow, B. et al. | 2007
- S208
-
S.21.03 Treatment-resistant social anxiety disorderStein, D. J. et al. | 2007
- S210
-
S.22.04 Neural correlates of negative and affective symptomsStip, E. / Fahim, C. / Mancini-Marie, A. / Ait Bentaleb, L. / Mensour, B. et al. | 2007
- S211
-
S.23.03 ACE gene polymorphisms and depression: relation to cardiovascular diseaseBaghai, T. C. / Haefner, S. / Born, C. / Eser, D. / Schuele, C. / Zill, P. / Bedarida, G. / von Schacky, C. / Rupprecht, R. / Bondy, B. et al. | 2007
- S213
-
S.24.03 Models of schizophrenia and early life trauma in rodentsEllenbroek, B. A. et al. | 2007
- S214
-
S.25.03 Predicting the effect of different anti-craving drugs on relapseKiefer, F. et al. | 2007
- S215
-
S.26.01 From sacred plants to psychotherapy: the history and re-emergence of psychedelics in medicineSessa, B. et al. | 2007
- S216
-
S.26.04 Is the combination of SSRIs with cognitive behavioural therapy the best treatment option for patients with anxiety disorders?van Balkom, A. J. et al. | 2007
- S217
-
S.28.01 Tryptophan metabolism and psychiatric disordersFuchs, D. / Sperner-Unterweger, B. et al. | 2007
- S218
-
S.28.03 Kynurenic acid actions in brain and peripheryMoroni, F. et al. | 2007
- S221
-
E.01.03 Endophenotypes in addictionHeinz, A. / Wrase, J. / Puls, I. / Beck, A. et al. | 2007
- S223
-
E.04.03 The impact of publicly-funded vs. industry-funded AD trials on clinical practiceSchneider, L. S. et al. | 2007
- S224
-
E.06.03 The influence of psychotropic medication on the reproductive endocrine milieuMcIntyre, R. et al. | 2007
- S227
-
P.1.a.002 Expression of hippocampal NR1 subunit of NMDA receptor in heuristic and genetic model of schizophreniaStastny, F. / Vrajova, M. / Tejkalova, H. / Pekova, S. / Kozmikova, I. et al. | 2007
- S228
-
P.1.a.003 Serotonin transporter gene polymorphism associated with venlafaxine treatment responseChoi, T. K. / Koo, M. S. / Lee, S. H. / Seok, J. H. / Kim, S. J. et al. | 2007
- S229
-
P.1.a.005 Polymorphisms in D-amino acid oxidase and D-amino acid oxidase activator genes and homicidal behaviors in schizophreniaJung, J. / Hong, J. P. / Chung, S. C. et al. | 2007
- S230
-
P.1.a.006 SLC6A4 promoter (5-HTTLPR) and BDNF Val66Met polymorphisms are associated with response to rTMS in depressed subjectsBocchio Chiavetto, L. / Miniussi, C. / Zanardini, R. / Gazzoli, A. / Bignotti, S. / Specchia, C. / Gennarelli, M. et al. | 2007
- S231
-
P.1.a.008 Catechol-O-methyltrasferase gene polymorphism (Val/Met) is not associated with bipolar disorderChee, I. S. / Lee, S. W. / Kim, J. L. / Kim, Y. H. / Park, J. S. / Lee, Y. H. / Wang, S. K. et al. | 2007
- S232
-
P.1.a.010 Serotonin transporter gene polymorphism and personality traits in eating disordersAbraham, I. / Bokor, S. / Fenyvesi, I. / Molnar, D. / Voros, V. / Osvath, P. / Gati, A. et al. | 2007
- S234
-
P.1.a.013 Association study of single nucleotide polymorphisms on catechol-O-methyltransferase gene in Korean patients with schizophreniaChulkwon, K. / Kim, J. W. / Lee, D. K. et al. | 2007
- S235
-
P.1.a.015 Neuregulin-1 risk haplotype and eye movements in schizophreniaHaraldsson, M. / Ettinger, U. / Magnusdottir, B. B. / Sigmundsson, T. / Sigurdsson, E. / Petursson, H. et al. | 2007
- S236
-
P.1.a.016 Epigenetic dysregulation of DAT and DRD2 but not DRD1 and DRD4 mRNA expression in females with eating disordersFrieling, H. / Scholz, S. / Mittelbach, F. / de Zwaan, M. / Kornhuber, J. / Hillemacher, T. / Bleich, S. et al. | 2007
- S237
-
P.1.a.018 Changes in the expression of NR1 subunit of NMDA receptor in schizophrenic hippocampusVrajova, M. / Pekova, S. / Klaschka, J. / Stastny, F. et al. | 2007
- S239
-
P.1.a.021 Association of a triallelic polymorphism of the serotonin transporter gene with suicidal behaviourKhalilova, Z. / Gaisina, D. et al. | 2007
- S240
-
P.1.b.002 Platelet 3H-imipramine, 3H-paroxetine and 5-HT2 binding sites in bipolar disorderCustal, N. / Crespo, J. M. / Morchon, S. / Rosel, P. / Soria, V. / Hernandez, R. / Cardoner, N. / Urretavizcaya, M. / Menchon, J. M. / Vallejo, J. et al. | 2007
- S242
-
P.1.c.001 The effects of two different types of chronic morphine pretreatment on anxiety and nociception in adolescence offspringDobryakova, Y. V. / Dubynin, V. A. / Kamensky, A. A. / Shamakina, I. Y. / Anokhina, I. P. et al. | 2007
- S243
-
P.1.c.003 D-cycloserine improves an impairment in reversal learning induced by phencyclidine in the ratIdris, N. / Grayson, B. / Neill, J. C. et al. | 2007
- S244
-
P.1.c.005 Influence of inhibitory neurotransmitters on glutamate release and chloride content in rat brain synaptosomesFedorovich, S. / Waseem, T. et al. | 2007
- S246
-
P.1.c.008 Various ethanol doses combined with morphine 30 mg do not affect pharmacodyanmic and pharmacokinetic measuresSetnik, B. / Sellers, E. M. / Miguelez, M. et al. | 2007
- S247
-
P.1.c.010 Gender-dependent influence of bupropion pretreatment on locomotor activity and the activity of hepatic CYP2D2 in ratsZahradnikova, L. / Zendulka, O. / Jurica, J. / Hadaova, E. et al. | 2007
- S248
-
P.1.c.012 Effects of calcium antagonists on diazepam withdrawal in ratsGenkova-Papazova, M. / Petkova, B. / Lazarova-Bakarova, M. B. et al. | 2007
- S249
-
P.1.c.014 The influence of prenatal administration of arginine-vasopressin on the postpound behaviour in white ratsVoskresenskaya, O. / Kamensky, A. / Golubovich, V. et al. | 2007
- S251
-
P.1.c.017 Morphine-induced locomotor sensitization increases FADD phosphorylation in rat brainRamos-Miguel, A. / Miralles, A. / Garcia-Sevilla, J. A. et al. | 2007
- S252
-
P.1.c.019 Stress related disorders: the transnosografic dimensionCatena, M. / Gorini Amedei, S. / Rotella, F. / Faravelli, L. / Ricca, V. / Consoli, G. / Palla, A. / Ciampa, G. / Faravelli, C. et al. | 2007
- S253
-
P.1.c.021 The effect of nicotine and mecamylamine on spatial memory in ratsCzubak, A. / Nowakowska, E. / Kus, K. / Matschay, A. / Kokot, Z. et al. | 2007
- S254
-
P.1.c.022 PET-measured D2, 5-HT2, and norepinephrine transporter (NET) occupancy by quetiapine and N-desalkyl-quetiapine in non-human primatesNyberg, S. / Takano, A. / Grimm, S. / Gulyas, B. / McCarthy, D. / Lee, C. / Goldstein, J. / Halldin, C. / Farde, L. et al. | 2007
- S255
-
P.1.c.024 Tolerability of the 5-hydroxytryptophane challenge test with granisetron and domperidoneJacobs, G. E. / Hoeberechts-Lefrandt, L. J. / de Kam, M. L. / Zitman, F. G. / van Gerven, J. M. et al. | 2007
- S256
-
P.1.c.026 Acetylcholinesterase protection by donepezil against organophosphate toxicityZivin, M. / Saghafi, M. / Pregelj, P. et al. | 2007
- S258
-
P.1.c.029 Brain-derived neurotrophic factor downregulation in rat brain following sub-chronic phencyclidine administrationSnigdha, S. / Neill, J. C. / Shahid, M. / Cruise, L. / Henry, B. et al. | 2007
- S259
-
P.1.c.031 Role of CB1 receptors in the basolateral amygdala in conditioned aversion, associated analgesia and neuronal activationRoche, M. / Johnson, P. / Ni Mhuircheartaigh, O. / Finn, D. F. et al. | 2007
- S261
-
P.1.c.034 Induction of carbamazepine metabolism during co-treatment with phenobarbitone - a population pharmacokinetic studyVucicevic, K. / Miljkovic, B. / Petronijevic, M. / Pokrajac, M. / Velickovic, R. / Grabnar, I. et al. | 2007
- S262
-
P.1.c.036 Cholinesterase activity in rat brains treated with diazepam co-administered with rivastigmine, galantamine or tacrineDimitrova, D. / Argirova, M. / Getova, D. / Mihailova, A. et al. | 2007
- S263
-
P.1.c.038 Progesterone induced-changes in gene expression of d subunit gabaa receptor in rat hippocampal neurons in cultureMostallino, M. C. / Mura, M. L. / Maciocco, E. / Murru, L. / Sanna, E. / Biggio, G. et al. | 2007
- S264
-
P.1.c.039 Increased midbrain dopaminergic firing by the competitive N-methyl-D-aspartate receptor antagonist SDZ 220-581Olsson, S. K. / Linderholm, K. / Erhardt, S. / Engberg, G. et al. | 2007
- S265
-
P.1.c.041 Immediate and long term effects of perinatal phencyclidine treatment on the acetylcholinesterase activity in rat brainPetronijevic, N. D. / Radonjic, N. V. / Simic, S. / Simonovic, M. / Paunovic, V. R. et al. | 2007
- S266
-
P.1.c.042 Long term effects of perinatal phencyclidine treatment on superoxide dismutase (SOD) activity and distribution in neurons in rat brainRadonjic, N. V. / Petronijevic, N. D. / Kravic, T. / Puskas, L. / Djuricic, B. / Bumbasirevic, V. et al. | 2007
- S267
-
P.1.c.044 Improvement of AMPA antagonist activity by methyl substitution on the aniline ring of 2,3-benzodiazepine derivativesKertesz, S. / Vegh, M. / Kapus, G. / Gigler, G. / Wellmann, J. / Szenasi, G. / Barkoczy, J. / Harsing, L. G. / Simig, G. / Levay, G. et al. | 2007
- S268
-
P.1.c.046 Asenapine displays high affinity and potent antagonism at an ensemble of human serotonin receptor subtypesShahid, M. / Wong, E. H. et al. | 2007
- S269
-
P.1.c.047 Asenapine: long-term and dose-dependent effects on adrenergic and muscarinic cholinergic receptors in rat brainShahid, M. / Choi, Y. K. / Gardner, M. / Wong, E. H. / Henry, B. / Tarazi, F. I. et al. | 2007
- S270
-
P.1.c.049 Symptoms of post-traumatic stress disorder: examination of factor structure in two separate clinical trialsStein, D. / Rothbaum, B. O. / Baldwin, D. S. / Tian, X. W. / Pedersen, R. / Ahmed, S. / Davidson, J. R. et al. | 2007
- S271
-
P.1.c.051 Medial septal 5-HT1A and NMDA receptors interact in the control of hippocampal-dependent memoryElvander-Tottie, E. / Eriksson, T. M. / Sandin, J. / Ogren, S. O. et al. | 2007
- S272
-
P.1.c.053 Comparative study of the effects of tacrine, donepezil and rivastigmine in rats with diazepam-induced amnesiaDimitrova, D. / Getova, D. et al. | 2007
- S273
-
P.1.d.001 Comparison of effects of different types of environmental enrichment on behaviour of C57/BL mice in plus-maze-testPokk, P. / Okva, K. / Lang, A. / Nevalainen, T. et al. | 2007
- S274
-
P.1.d.003 Stress-induced c-fos expression in adolescent 6-hydroxydopamine lesioned ratsChung, Y. C. / Lee, C. R. / Kim, K. W. et al. | 2007
- S275
-
P.1.d.005 PDE10A2, a striatal medium spiny neuron-specific phosphodiesterase, regulates social interactionYokoi, M. / Sano, H. et al. | 2007
- S277
-
P.1.d.008 Effects on the adult behavioral changes of early maternal separation during the stage of development in the ratChung, Y. / Park, S. H. / Kim, G. J. / Seo, Y. N. et al. | 2007
- S278
-
P.1.d.010 Interaction between dopaminergic and food derived opioid regulation of mother dependent behaviour of albino rat pupsStovolosov, I. S. / Dubynin, V. A. / Kamensky, A. A. et al. | 2007
- S279
-
P.1.d.012 Gender-specific effects of prenatal hypoxic stress in the period of early organogenesisGraf, A. / Trofimova, L. / Maslova, M. / Dunaeva, T. / Krushinskaya, J. A. / Goncharenko, E. / Bayzhymanov, A. et al. | 2007
- S280
-
P.1.e.001 Dehydroepiandrosterone (DHEA) possesses antiglucocorticoid effects on serotonin-1A receptors in the hypothalamusMoser, U. / Lanzenberger, R. / Stein, P. / Spindelegger, C. / Wadsak, W. / Mitterhauser, M. / Holik, A. / Mien, L. K. / Kletter, K. / Kasper, S. et al. | 2007
- S281
-
P.1.e.002 Longitudinal assessment of white matter in schizophrenia: a combined diffusion-tensor and structural MR imaging studyMitelman, S. A. / Torosjan, Y. / Newmark, R. E. / Buchsbaum, M. S. et al. | 2007
- S282
-
P.1.e.004 The neural substrates of affective face recognition in patients with Hwa-Byung and healthy individuals in KoreaHam, B. J. / Kim, J. W. / Lim, W. J. / Paik, J. W. / Kang, R. H. / Lee, M. S. et al. | 2007
- S283
-
P.1.e.006 The effect of eye movement desensitization and reprocessing (EMDR) treatment in hippocampal volumes of post-traumatic stress disorder patientsBossini, L. / Tavanti, M. / Calossi, S. / Lombardelli, A. / Polizzotto, N. / Galli, R. / Vatti, G. / Pieraccini, F. / Castrogiovanni, P. et al. | 2007
- S284
-
P.1.e.007 Decreased cerebellar blood volume in schizophrenia: a perfusion weighted imaging studyBaiano, M. / Bellani, M. / Rambardelli, G. / Perlini, C. / Umit, T. / Cerini, R. / Balestrieri, M. / Tansella, M. / Brambilla, P. et al. | 2007
- S285
-
P.1.e.009 The neural correlates of reduced dopamine and serotonin in mood and reinforcementLythe, K. E. / Elliott, R. / Anderson, I. M. / Deakin, J. F. et al. | 2007
- S286
-
p,1.e.011 Positive correlation between theory of mind deficit and gray matter changes in patients with schizophreniaHerold, R. / Feldmann, A. / Tenyi, T. / Kover, F. / Nagy, F. / Fekete, S. et al. | 2007
- S288
-
P.1.e.014 Subjective effects of acute dose of hydrocortisone in healthy volunteersTyacke, R. J. / Reid, A. / Holmes, R. / Grant, E. / Zelaya, F. / Reul, J. M. / Lightman, S. / Williams, S. C. / Nutt, D. J. / Malizia, A. L. et al. | 2007
- S289
-
P.1.e.016 No changes in 5-HT1A receptor and serotonin transporter between phases of the menstrual cycle in healthy womenJovanovic, H. / Karlsson, P. / Cerin, A. / Halldin, C. / Nordstrom, A. L. et al. | 2007
- S290
-
P.1.e.017 Lateral ventricle volume is related to lipid peroxidation in male patients with first episode psychosisFraguas, D. / Reig, S. / Desco, M. / Rojas, O. / Mico, J. A. / Parellada, M. / Moreno, D. / Arango, C. et al. | 2007
- S291
-
P.1.e.019 Size, FDG-PET activity, and neuroleptic responsivity of the medialdorsal nucleus of the thalamus in schizophreniaBuchsbaum, M. / Byne, W. / Chu, K. W. / Goldstein, K. / Goodman, C. / Haznedar, M. M. / Hazlett, E. A. / Kemether, E. / Newmark, R. / Torosjan, Y. et al. | 2007
- S292
-
P.1.e.021 Stressful life events bias neural correlates of moral valence decision in patients affected by mood disorderRadaelli, D. / Bernasconi, A. / Dallaspezia, S. / Poletti, S. / Benedetti, F. / Falini, A. / Colombo, C. et al. | 2007
- S294
-
P.1.e.024 Elevated striatal dopaminergic function is related to `prodromal psychotic' symptoms prior to the onset of schizophreniaHowes, O. / Montgomery, A. J. / Valli, I. / Asselin, M. C. / Murray, R. M. / McGuire, P. K. / Grasby, P. M. et al. | 2007
- S295
-
P.1.e.026 A functional MRI study of the brain and interpersonal behaviour in schizophrenia. A preliminary studyRylands, A. / Deakin, J. F. / Tarrier, N. / Elliot, R. / McKie, S. et al. | 2007
- S296
-
P.1.f.001 Neuropsychological functioning in stabilized patients after a first psychotic episode: bipolar versus schizophreniaPerez de Heredia, J. L. / Barbeito, S. / Mosquera, F. / Lopez, P. / Haidar, K. / Gonzalez-Pinto, A. et al. | 2007
- S297
-
P.1.f.003 Are schizophrenia and bipolar I disorder seperate disease entities? A study with neurocognitive performanceLee, Y. S. / Lee, Y. / Yoo, J. / Park, J. / Park, S. / Lee, W. et al. | 2007
- S298
-
P.1.f.005 Temperament and character of suicide attempters compared to healthy subjectsCalati, R. et al. | 2007
- S299
-
P.1.f.006 Cognitive versus emotional decision-making in healthy subjects using the Game of Dice Task and the Iowa Gambling TaskJeong, S. / Seo, Y. / Kim, Y. / Lee, Y. / Rim, H. / Park, Y. / Jeong, I. / Lee, K. et al. | 2007
- S300
-
P.1.f.008 A challenging task for assessment of checking behaviors in obsessive-compulsive disorderRotge, J. Y. / Clair, A. H. / Jaafari, N. / Hantouche, E. G. / Pelissolo, A. / Guehl, D. / Burbaud, P. / Tignol, J. / Mallet, L. / Aouizerate, B. et al. | 2007
- S301
-
P.1.f.009 Neurocognitive dysfunction in patients with bipolar type I disorder in remission: are mood symptoms responsible?Videira Dias, V. / Brissos, S. / Simon, L. / Duarte, P. / Vicente Castro, F. et al. | 2007
- S302
-
P.1.g.001 Hypothalamic hamartoma and psychiatryVerhoeven, W. M. / Veendrick-Meekes, M. J. / Van Erp, M. G. / Van Blarikom, W. / Tuinier, S. et al. | 2007
- S303
-
P.1.g.003 Prediction of a cardiac cycle appearance by the activity of dorso-medial medullar neurons in ratsPrudnikau, H. / Soltanov, V. et al. | 2007
- S304
-
P.1.g.004 Smoking influences global DNA methylationHillemacher, T. / Frieling, H. / Bleich, S. / Muschler, M. A. / Moskau, S. / Linnebank, M. et al. | 2007
- S305
-
P.1.g.006 Emotion recognition vs. non-affective visual processing deficits in schizophreniaErmilov, M. / Elran, S. / Levin, R. / Edelman, S. / Javitt, D. / Heresco-Levy, U. et al. | 2007
- S307
-
P.1.g.009 Taurine in plasma and CSF - a study in healthy male volunteersNordin, C. / Dahl, M. L. / Gupta, R. C. / Samuelsson, M. et al. | 2007
- S308
-
P.1.g.011 The cortisol awakening response in mood, anxiety and somatoform disorders - additional impact of severity and sleep qualityVeen, G. / van Vliet, I. M. / de Rijk, R. H. / Zitman, F. G. et al. | 2007
- S309
-
P.1.g.013 Hypothalamic-pituitary-adrenal axis activity in healthy males and femalesOzsoy, S. / Esel, E. / Kartalci, S. et al. | 2007
- S310
-
P.1.g.015 Neurotransmitter-induced store-operated calcium entry is strictly dependent on the mitochondria functioningKopach, O. / Kruglikov, I. / Voitenko, N. / Fedirko, N. et al. | 2007
- S312
-
P.2.a.002 Plasma BDNF as a peripheral marker for the action mechanism of antidepressantsKim, Y. K. / Lee, H. Y. et al. | 2007
- S313
-
P.2.a.004 The impact of ziprasidone on visually-evoked event-related potentials in depressed patients with psychotic featuresMo ller, O. / Evers, S. / Deckert, J. / Baune, B. T. / Dannlowski, U. / Nguyen, D. H. / Arolt, V. / Hetzel, G. et al. | 2007
- S314
-
P.2.a.006 Korean medication algorithm for depressive disorder 2006(I)Seo, J. S. / Min, K. J. / Kim, W. / Seok, J. H. / Bahk, W. M. / Song, H. C. et al. | 2007
- S315
-
P.2.a.007 Beta-adrenergic receptor responsiveness may predict treatment response in panic disorderKang, E. H. / Cho, H. W. / Kim, Y. C. / Cheo, H. D. / Yu, B. H. et al. | 2007
- S316
-
P.2.a.009 Efficacy of tianeptine in the treatment of depressive disorders according to Hamilton depression rating scaleMargaryan, S. P. / Sukiasyan, S. H. / Manasyan, N. G. / Babakhanyan, A. A. / Kirakosyan, A. L. et al. | 2007
- S317
-
P.2.a.011 Tolerability and safety of escitalopram in randomised controlled trials in major depression and anxiety disordersBaldwin, D. et al. | 2007
- S318
-
P.2.a.012 Genetic bases of comorbidity between mood disorders and migraine: possible role of serotonin transporter geneLorenzi, C. / Bongiorno, F. / Marino, E. / Pirovano, A. / Franchini, L. / Smeraldi, E. et al. | 2007
- S319
-
P.2.a.014 Circulating brain-derived neurotrophic factor (BDNF)in depressed patients during one year of antidepressant treatment.Catena, M. / Del Debbio, A. / Schiavi, E. / Palla, A. / Bianchi, C. / Roncaglia, I. / Mariotti, A. / Marazziti, D. / Piccinni, A. / DellOsso, L. et al. | 2007
- S320
-
P.2.a.016 Prevalence and clinical correlates of pain in patients with recurrent major depressive disorderAhmed, S. / Schatzberg, A. F. / Friedman, E. S. / Rothschild, A. J. / Trivedi, M. H. / Dunner, D. L. / Gelenberg, A. / Ninan, P. / Shelton, R. / Zajecka, J. M. et al. | 2007
- S321
-
P.2.a.017 Symptomatic and functional remission of depression in a large observational study (OREON 2)Mignon, A. / Demyttenaere, K. / Ansseau, M. / McIntyre, R. S. / Albert, A. et al. | 2007
- S322
-
P.2.a.019 Association study of the 5-HTT polymorphism and mirtazapine antidepressant response in major depressive disorderKang, R. H. / Kim, J. G. / Choi, M. J. / Lee, H. W. / Kang, S. G. / Lee, H. J. / Lee, M. S. et al. | 2007
- S323
-
P.2.a.021 The influence of subthreshold depression on cognition and quality of life in Korean elderlyPark, J. H. / Choi, Y. S. / Lee, S. B. / Choi, E. A. / Shin, K. C. / Kim, K. W. et al. | 2007
- S324
-
P.2.a.022 Prevalence of pain in depression and health related quality of life outcomes: results from the FINDER studyDemyttenaere, K. / Yurgin, N. / Reed, C. / Quail, D. / Dantchev, N. / Montejo, A. L. / Monz, B. / Bauer, M. / Tylee, A. / Grassi, L. et al. | 2007
- S325
-
P.2.a.024 Social support in anxious and depressive outpatientsVidal Millares, M. / Espino Diaz, I. / Brenlla Gonzalez, J. / Garcia Mahia, M. C. et al. | 2007
- S326
-
P.2.a.026 Predicting treatment outcome in difficult-to-treat depressed patientsCamardese, G. / Mosca, L. / Picello, A. / Morelli, C. / Adamo, F. / Pucci, L. / Mattioli, B. / Bria, P. et al. | 2007
- S327
-
P.2.a.027 Cross cultural aspects of depression among college studentsParikh, R. / Sonawalla, S. / Sharma, S. / Farabaugh, A. / Yeung, A. / Safren, S. / Fava, M. et al. | 2007
- S328
-
P.2.a.029 Impact of vagus nerve stimulation therapy on cost of care in chronic or recurrent depressive patients resistant to treatmentAnnemans, L. / Audenaert, K. / Van der Aa, H. / Buschman, R. / Vanderstappen, D. / Welkenhuysen, J. et al. | 2007
- S329
-
P.2.a.031 Autobiographical memory in depressed patients treated with clomipramine or venlafaxineFerreri, F. / Agbokou, C. / Gierski, F. / Charrel, C. L. / Peretti, C. S. et al. | 2007
- S330
-
P.2.a.033 Treatment resistant depression: prednisolone suppression test predicts response to inpatient treatmentJuruena, M. F. / Cleare, A. J. / Papadopoulos, A. S. / Poon, L. / Lightman, S. L. / Pariante, C. M. et al. | 2007
- S331
-
P.2.a.034 The relation between cytokines or neurotrophic factors of plasma and cognitive or somatic symptoms of major depressionLee, B. H. / Kim, Y. K. / Na, K. S. et al. | 2007
- S332
-
P.2.b.001 Treatment with electroconvulsive therapy is associated with an increase of nitric oxide synthesisHoekstra, R. / Fekkes, D. / Loonen, A. J. / Tuinier, S. / Verhoeven, W. M. et al. | 2007
- S333
-
P.2.b.003 Modulation of Arc and BDNF following acute and chronic administration of agomelatine in ratsCalabrese, F. / Pescara, F. / Racagni, G. / Mocaer, E. / Molteni, R. / Riva, M. A. et al. | 2007
- S334
-
P.2.b.005 Polymorphisms in cytosolic phospholipase A2 and cyclooxygenase 2 genes and risk of interferon-induced depressionSu, K. P. / Peng, C. Y. / Liao, K. F. / Lai, H. C. / Huang, C. L. / Cheng, J. C. / Aitchison, K. J. / Pariante, C. M. et al. | 2007
- S336
-
P.2.b.008 Acute tryptophan depletion increases plasma prolactin in women but not menHood1+, S. / Hince, D. A. / Robinson, H. / Christmas, D. / Nutt, D. J. et al. | 2007
- S337
-
P.2.b.010 SSRI clinical efficacy and plasma prolactin level after single oral dose of buspirone in patients with major depressionCubala, W. J. / Landowski, J. / Sowinski, P. / Wichowicz, H. M. et al. | 2007
- S338
-
P.2.b.012 Plasma cortisol levels and resilience in depressed patientsCamardese, G. / Adamo, F. / Mosca, L. / Picello, A. / Pizi, G. / Mattioli, B. / Pucci, L. / Bria, P. et al. | 2007
- S340
-
P.2.b.015 Gender and the dexamethasone suppression test threshold in suicide predictionJokinen, J. / Nordstrom, A. L. / Nordstrom, P. et al. | 2007
- S341
-
P.2.c.002 Therapeutic latency of escitalopramCornutiu, G. / Fordon, A. / Cornutiu, O. et al. | 2007
- S342
-
P.2.c.003 All for one or one for all - assessing the true treatment effect of active vs placebo therapy in severe major depressive disorderThase, M. E. / Kennedy, S. H. et al. | 2007
- S343
-
P.2.c.005 Impact of tianeptine on cognitive functions in depressed patientsKlasik, A. / Krupka-Matuszczyk, I. / Krysta, K. / Przybylo, J. / Czech, K. / Macyszyn, M. et al. | 2007
- S344
-
P.2.c.007 What lets patients under antidepressants get stuck in their recovery after initial improvement?Stassen, H. / Angst, J. / Scharfetter, C. / Szegedi, A. et al. | 2007
- S346
-
P.2.c.010 Quetiapine augmentation in depressed patients with partial or no response to antidepressantsOlver, J. S. / Ignatiadis, S. / Burrows, G. D. / Norman, T. R. et al. | 2007
- S347
-
P.2.c.012 Duloxetine in seasonal affective disorder: results of an open trialPjrek, E. / Praschak-Rieder, N. / Willeit, M. / Konstantinidis, A. / Kasper, S. / Winkler, D. et al. | 2007
- S348
-
P.2.c.014 Mecamylamine as an augmentation treatment for depressed patients who were non-responders to citalopramDunbar, G. / Kuchibhatla, R. / Kumar, R. et al. | 2007
- S349
-
P.2.c.016 Comparative efficacy of escitalopram and duloxetine in the acute treatment of major depressive disorderBose, A. / Gommoll, C. / Li, D. / Gandhi, C. et al. | 2007
- S350
-
P.2.c.018 Does pindolol reduce latency of action of SSRI administered intravenously?Oller, S. / Portella, M. J. / Puigdemont, D. / Perez, V. / Alvarez, E. / Artigas, F. et al. | 2007
- S351
-
P.2.c.019 Korean medication algorithm for depressive disorder 2006(IV): treatment strategy according to the clincal situationsJeon, H. T. / Lee, S. Y. / Kim, W. / Min, K. J. / Bahk, W. M. / Seo, J. S. / Seok, J. H. / Song, H. C. / Jon, D. I. / Hong, J. P. et al. | 2007
- S352
-
P.2.c.021 Venlafaxine in elderly patients with depressionKrsteska, R. / Icevska, L. / Filovska, V. et al. | 2007
- S353
-
P.2.c.023 Switching to duloxetine from SSRI non- and partial-responders: does the type of SSRI prior to switch influence outcomes?Perahia, D. / Quail, D. / Desaiah, D. / Gilaberte, I. / Haddad, P. et al. | 2007
- S354
-
P.2.c.025 Antidepressants in treatment of eating disordersCeskova, E. / Valentova, D. / Palcikova, I. / Dufek, J. / Dockalova, R. et al. | 2007
- S355
-
P.2.c.026 Efficacy and tolerability of escitalopram in patients with depression vs depression with comorbid anxietyLampousi, E. / Stamouli, S. / Liakouras, A. / Panagoutsos, P. et al. | 2007
- S356
-
P.2.c.028 Duloxetine hepatic effects: 2006 reviewPerahia, D. / Acharya, N. / Wang, F. / Strombom, I. / DSouza, D. / Wernicke, J. et al. | 2007
- S357
-
P.2.c.030 Melancholic and nonmelancholic subtype of depression and efficacy of antidepressants treatmentRajewska-Rager, A. / Kapelski, P. / Dmitrzak-Weglarz, M. / Hauser, J. et al. | 2007
- S359
-
P.2.c.033 Venlafaxine-treatment in female patients with depressive disorder in menopausal periodFilovska, V. / Jakovchevska-Kujundziska, M. / Krsteska, R. / Dimova, O. et al. | 2007
- S360
-
P.2.c.035 Escitalopram in clinical practice: effects on disability caused by depressionStamouli, S. / Ifantis, A. / Tzanakaki, M. / Zouganelli, A. et al. | 2007
- S361
-
P.2.c.038 Long-term efficacy of agomelatine, a novel antidepressant, in the prevention of relapse in out-patients with major depressive disorderGoodwin, G. M. / Rouillon, F. / Emsley, R. et al. | 2007
- S362
-
P.2.d.002 The effects of paroxetine and venlafaxine on cytokines in animal model of depressionManikowska, K. / Szczawinska, K. / Bobkiewicz-Kozlowska, T. / Cenajek-Musial, D. / Lesniewska, K. et al. | 2007
- S363
-
P.2.d.003 Effect of tramadol on corticosteroid receptor function in patients with major depressionMinenko, S. et al. | 2007
- S364
-
P.2.d.005 Comparison of agomelatine and melatonin for effects in chronically stressed tree shrews, an animal model of depressionCorbach, S. / Schmelting, B. / Fuchs, E. / Mocaer, E. et al. | 2007
- S365
-
P.2.d.007 TC-5214 ((S)-(+)-Mecamylamine) demonstrates antidepressant and anxiolytic effects in multiple animal modelsBencherif, M. / Gatto, G. J. / Jordan, K. G. / Lippiello, P. M. et al. | 2007
- S366
-
P.2.d.008 Evaluation of cognition enhancing properties of agomelatine in the object recognition task in ratsBertaina-Anglade, V. / Seguin, L. / Mocaer, E. / Drieu La Rochelle, C. et al. | 2007
- S367
-
P.2.d.010 In vivo effect of venlafaxine on locus coeruleus neurons: role of opioid, alpha2-adrenergic and 5-HT1A receptorsBerrocoso, E. / Mico, J. A. et al. | 2007
- S368
-
P.2.d.012 Vagus nerve stimulation: effects on noradrenergic neuronal firing and serotonin transmission in the rat brainManta, S. / Dong, J. / Blier, P. / Debonnel, G. et al. | 2007
- S369
-
P.2.d.014 Escitalopram modulates fear conditioning in ratsMontezinho, L. / Miller, S. / Plath, N. / Mork, A. et al. | 2007
- S370
-
P.2.d.016 Effects of long-term treatment with bupropion on the firing activity of serotonin and norepinephrine neuronsEl Mansari, M. / Ghanbari, R. / Janssen, S. / Blier, P. et al. | 2007
- S371
-
P.2.d.018 Effects from vagus nerve stimulation on rat hippocampal progenitor proliferationRevesz, D. / Tjernstrom, M. / Ben-Menachem, E. / Thorlin, T. et al. | 2007
- S372
-
P.2.d.020 SNRI effective treatment does not restore changes of immune and inflammatory parameters in depressed patientsCamardese, G. / Pizi, G. / Bartoccioni, E. / Grillo, R. L. / Ricci, V. / Picello, A. / Morelli, C. / Bria, P. et al. | 2007
- S373
-
P.2.d.021 Distinct electrophysiological effects of citalopram and escitalopram on mesolimbic dopamine neuronal activity in ratsDremencov, E. / El Mansari, M. / Blier, P. et al. | 2007
- S374
-
P.2.d.023 Effects of tricyclic antidepressants on intestinal pacemaker cellsKim, S. H. / Hwang, G. / Kim, H. R. / Park, S. H. / Jeon, J. Y. et al. | 2007
- S375
-
P.2.d.025 Lack of association of 1287A/G NET and Val66Met BDNF polymorphisms with response to antidepressantsSzczepankiewicz, A. / Rajewska-Rager, A. / Dmitrzak-Weglarz, M. / Gattner, K. / Kapelski, P. / Kaczmarkiewicz-Fass, M. / Slopien, A. / Leszynska-Rodziewicz, A. / Hauser, J. et al. | 2007
- S377
-
P.2.e.002 Val/Met polymorphism of COMT gene in patients with bipolar affective illness treated with lithiumPermoda-Osip, A. / Suwalska, A. / Dmitrzak-Weglarz, M. / Skibinska, M. / Czerski, P. / Hauser, J. / Rybakowski, J. K. et al. | 2007
- S378
-
P.2.e.004 A meta-analysis of the effect of lithium on renal functionPaul, R. / Minay, J. / Cardwell, C. / Fogarty, D. / Stevenson, M. / Kelly, C. et al. | 2007
- S379
-
P.2.e.006 Clinical features of early onset bipolar disorderBahk, W. M. / Woo, Y. S. / Chae, J. H. / Jun, T. Y. / Seo, H. J. et al. | 2007
- S380
-
P.2.e.008 Searching susceptibility loci for mania: a sib pairs pilot studyPirovano, A. / Lorenzi, C. / Dotoli, D. / Bongiorno, F. / Marino, E. / Catalano, M. / Smeraldi, E. et al. | 2007
- S382
-
P.2.e.011 Heat-shock protein-70 genes in bipolar disorder and response to antimanic treatmentsMandelli, L. / Kim, J. J. / Serretti, A. / Pae, C. U. et al. | 2007
- S383
-
P.2.e.013 The efficacy and tolerability of zotepine for mania: an observational studyLin, W. W. / Chen, H. K. / Yeh, E. W. et al. | 2007
- S384
-
P.2.e.015 Early onset of antipsychotic action and time course in the treatment of acute bipolar maniaKetter, T. / Warrington, L. / Loebel, A. / Kolb, S. / Siu, C. et al. | 2007
- S385
-
P.2.e.017 Bipolar disorder treatment guidelines followed by Spanish psychiatrists. GAMEB StudyVieta, E. / Morralla, E. et al. | 2007
- S386
-
P.2.e.018 The effect of olanzapine monotherapy on subjective estimates of sleep in acute maniaYoon, B. / Bahk, W. / Lee, S. / Lee, J. / Jung, S. / Won, S. / Seo, J. / Jon, D. / Min, K. / Kim, M. et al. | 2007
- S387
-
P.2.e.020 Assessment of intellectual functioning of euthymic bipolar patientsSuwalska, A. / Janik, J. / Lojko, D. / Kisielewski, J. / Cyranik, H. / Rybakowski, J. K. et al. | 2007
- S388
-
P.2.f.002 Olanzapine versus divalproex and placebo for the treatment of mild to moderate mania associated with bipolar I disorderTohen, M. / Vieta, E. / Jay Amsterdam, J. / Aaronson, S. T. / Sun, B. / Bowden, C. / Banov, M. / Shekhar, A. / Oliff, H. S. / Kryzhanovskaya, L. et al. | 2007
- S389
-
P.2.f.003 Brain-derived neurotrophic factor as potential diagnostic biochemical marker of depressive stateVentriglia, M. / Bevacqua, M. G. / Zanardini, R. / Bocchio Chiavetto, L. / Fontana, M. / Bignotti, S. / Squitti, R. / Rossini, P. M. et al. | 2007
- S390
-
P.2.f.005 Membrane phospholipid distribution: a comparison between patient with schizophrenia and bipolar disorderTessier, C. / Wyckaert, S. / De Hert, M. / Peuskens, J. / Rainteau, D. / Humbert, L. / Trugnan, G. / Wolf, C. / Nuss, P. et al. | 2007
- S391
-
P.2.g.002 Evaluation of clinical course for depression with Arita-Morishita scale and MADRSArita, S. / Morishita, S. / Kinoshita, T. et al. | 2007
- S392
-
P.2.g.004 Repetitive transcranial magnetic stimulation for depression: a randomised controlled trial with 4-month follow-upMcLoughlin, D. M. / Mogg, A. / Pluck, G. / Eranti, S. / Landau, S. / Purvis, R. / Brown, R. G. / Howard, R. / Curtis, V. / Philpot, M. et al. | 2007
- S393
-
P.2.g.005 Relation between insomnia mood disorders and specific clinical and biochemical parameters in hemodialysis patientsBornivelli, C. / Alivanis, P. / Giannikouris, J. / Arvanitis, A. / Choustoulakis, J. / Georgopoulou, K. / Karvouniaris, N. / Zervos, A. et al. | 2007
- S394
-
P.2.g.007 Biomarkers for rapid identification of treatment effectiveness in major depression (BRITE-MD)Leuchter, A. F. / Cook, I. A. / Marangell, L. B. / Gilmer, W. S. / Burgoyne, K. S. / Howland, R. H. / Trivedi, M. H. / Zisook, S. / Fava, M. / Manberg, P. et al. | 2007
- S395
-
P.2.g.009 The level of social functioning and depression in patients with breast cancer after mastedtomyMishyk, Y. et al. | 2007
- S397
-
P.2.g.012 Clinical effectiveness of pramipexole on depressive symptoms in Parkinsons diseaseFricchione Parise, V. et al. | 2007
- S398
-
P.2.h.002 Paroxetine effects on emotions: a 4-week randomized placebo-controlled pilot study in psychologists and psychiatristsCasse-Perrot, C. / Nguyen, N. / Jouve, E. / Souville, M. / Boulenger, J. P. / Fallissard, B. / Lancedilcon, C. / Rouillon, F. / Besnier, N. / Blin, O. et al. | 2007
- S399
-
P.2.h.004 Anxiolytic effects of quetiapine in rat punished responding: mechanism of action and the role of D2 antagonismMaciag, C. / Smolka, J. / McLaughlin, J. / Hudzik, T. / Evenden, J. / Widzowski, D. et al. | 2007
- S400
-
P.2.h.005 Brain-derived neurotrophic factor gene val66met polymorphism and the association between stroke and depressionKim, J. M. / Kim, S. W. / Yang, S. J. / Shin, I. S. / Yoon, J. S. et al. | 2007
- S401
-
P.3.a.001 Remission in schizophrenia: old wine in new bottles?Verhoeven, W. M. / Tuinier, S. / Egger, J. I. / Eschauzier, J. C. et al. | 2007
- S402
-
P.3.a.003 Impact of state and trait anxiety on cognitive functions in schizophreniaJeczminska, K. / Kozmin, A. / Krawiec, A. / Jarnot, J. / Dusik, J. / Krysta, K. / Krupka-Matuszczyk, I. et al. | 2007
- S403
-
P.3.a.005 The effect of drug side-effects and negative symptoms on the depression level in patients with chronic schizophreniaLee, J. S. / Sea, S. H. et al. | 2007
- S404
-
P.3.a.006 Increased pituitary volume is a familial risk factor for schizophrenia but not for bipolar disorderMondelli, V. / McDonald, C. / Gabilondo, A. / Tournikioti, K. / Walshe, M. / Marshall, N. / Schulze, K. / Murray, R. M. / Dazzan, P. / Pariante, C. M. et al. | 2007
- S405
-
P.3.a.008 Efficacy and safety of long-acting risperidone injection after switching from antipsychotics in Chinese patientsLi, H. F. / Gu, N. F. / Zhou, M. / Jia, F. J. / Zhao, Z. H. / Fan, J. X. / Wang, G. / Sun, X. L. / Li, M. / Zhang, J. B. et al. | 2007
- S406
-
P.3.a.010 Early-phase psychosis with substance use andsubstance-induced psychosis: a retrospective study with 5-years follow upColasanti, A. / De Gaspari, I. F. / Rossattini, M. / Dragogna, F. / Moliterno, D. / Mauri, M. C. et al. | 2007
- S408
-
P.3.a.013 Decreased bone mineral density in patients with schizophrenia treated with risperidone or olanzapine.Wyszogrodzka-Kucharska, A. / Rabe-Jablonska, J. et al. | 2007
- S409
-
P.3.a.015 Relation between working memory and negative symptoms and other factors in patients with first episode of schizophreniaLibera, U. / Pawelczyk, T. / Rabe-Jablonska, J. et al. | 2007
- S411
-
P.3.a.018 Treatment compliance, insight and clinical variables: review of the literatureVanelli, I. / Coentre, R. / Levy, P. et al. | 2007
- S412
-
P.3.a.020 Sociodemographic and clinical characteristics of perinatal psychosisVladimirova, R. / Stoyanova, V. / Krastev, S. / Milanova, V. / Genchev, G. et al. | 2007
- S413
-
P.3.a.022 Anxiety disorders comorbidity in patients with psychoses in remission phase after hospitalizationPaggini, R. / Carmassi, C. / Taponecco, C. / Consoli, G. / Ciampa, G. / Lombardi, V. / Mundo, F. / Ciapparelli, A. / DellOsso, L. et al. | 2007
- S414
-
P.3.a.024 Elaboration of immigration and risk for non affective psychotic disordersWerbeloff, N. / Weiser, M. / Reichenberg, A. / Vishna, T. / Yoffe, R. / Lubin, G. / Shmushkevitz, M. / Noy, S. / Davidson, M. et al. | 2007
- S415
-
P.3.a.025 Sleep and circadian activity/rest disturbances in schizophrenia patients in comparison to unemployed healthy controlsWulff, K. / Joyce, E. M. / Middleton, B. / Foster, R. G. / Dijk, D. J. et al. | 2007
- S416
-
P.3.a.027 Splitting of nondeficit syndrome by the boundries of two clusters identified by cognitive neuropsychiatric mappingSzendi, I. / Cimmer, C. / Csifcsak, G. / Racsmany, M. / Szekeres, G. / Kovacs, Z. A. / Galsi, G. / Garab, E. A. / Boda, K. / Janka, Z. et al. | 2007
- S417
-
P.3.b.001 Restoration of latent inhibition in ovariectomized rats by neuroleptics requires estrogenArad, M. / Weiner, I. et al. | 2007
- S418
-
P.3.b.003 Comprehension of metaphors in patients with schizophreniaMossaheb, N. / Aschauer, H. N. / Pils, N. / Raab, M. / Willinger, U. et al. | 2007
- S419
-
P.3.b.004 Subchronic elevation of endogenous levels of kynurenic acid increase dopamine release in rat nucleus accumbensNilsson-Todd, L. K. / Andersson, L. A. / Schwieler, L. / Engberg, G. / Holtze, M. / Linderholm, K. R. / Olsson, E. / Olsson, S. K. / Erhardt, S. et al. | 2007
- S420
-
P.3.b.006 Kynurenine pathway enzymes and levels of brain kynurenic acid following Influenza virus infectionHoltze, M. / Asp, L. / Engberg, G. / Karlsson, H. / Schwieler, L. et al. | 2007
- S421
-
P.3.b.008 N-acetylcysteine prevents prenatal poly I:C-induced disruption of latent inhibition and increase in tyrosine hydroxylasePiontkewitz, Y. / Weiner, I. et al. | 2007
- S422
-
P.3.b.009 Enhanced amphetamine-induced dopamine release in rat nucleus accumbens following subchronic elevation of kynurenic acidAndersson, L. A. / Nilsson, L. K. / Schwieler, L. / Holtze, M. / Olsson, S. K. / Olsson, E. / Linderholm, K. / Engberg, G. / Erhardt, S. et al. | 2007
- S423
-
P.3.b.011 Associations of 5HT2A receptor gene polymorphisms with the age of onset and baseline symptomatology in schizophreniaOlajossy-Hilkesberger, L. / Godlewska, B. / Olajossy, M. / Marmurowska-Michalowska, H. et al. | 2007
- S424
-
P.3.c.002 Comparative tolerability of rapid-acting intramuscular olanzapine and short-acting typical intramuscular antipsychoticsCastle, D. / Kwon, D. H. / Novak, V. / Pidrman, V. / Udristoiu, T. / Ruiz, I. / McElroy, H. / Lowry, A. / Saylan, M. / Treuer, T. et al. | 2007
- S425
-
P.3.c.003 A real picture on treatment with aripiprazole to long-time on metabolic syndromeFranza, F. / Aquino, K. / Fasano, V. / Battista, A. / Dinelli, G. / Dinelli, U. et al. | 2007
- S426
-
P.3.c.005 Aripiprazole monotherapy in acute bipolar I mania: a randomized, placebo- & lithium-controlled study (CN138-135)Sanchez, R. / Torbeyns, A. / Marcus, R. N. / McQuade, R. D. / Forbes, R. A. et al. | 2007
- S427
-
P.3.c.007 A naturalistic evaluation of risperidone long-acting injection on nine patients in a high secure hospitalVan Hoecke, E. et al. | 2007
- S429
-
P.3.c.010 Lamotrigine augmentation of clozapine antiagressive properties in a patient with chronic disorganized schizophreniaPavlovic, Z. et al. | 2007
- S430
-
P.3.c.012 Intramuscular and orodispersable olanzapine efficiency in the acute treatment of manic episodesVasile, D. / Vasiliu, O. / Paraschiv, S. / Vasile, M. / Terpan, M. et al. | 2007
- S431
-
P.3.c.014 Psychiatrists attitudes to antipsychotic depots I: clinician preferences and patient choiceHaddad, P. M. / McLaughlin, S. / Cunningham, P. / David, A. S. / Patel, M. X. et al. | 2007
- S433
-
P.3.c.017 Influence of atypical neuroleptic quetiapine on the serum dehydroepiandrosterone/ cortisol ratio in schizophreniaFedorenko, O. Y. / Ivanova, S. A. / Loginov, V. N. / Semke, A. V. et al. | 2007
- S434
-
P.3.c.019 Reduced supramarginal alpha power after 4-weeks antipsychotic treatment in schizophrenic patientsShin, C. J. / Park, D. H. et al. | 2007
- S436
-
P.3.c.022 A new validated method for classifying psychotic patients regarding treatment response: CANSEPTAlenius, M. / Hammarlund-Udenaes, M. / Hartvig, P. / Sundquist, S. / Lindstrom, L. et al. | 2007
- S437
-
P.3.c.024 Differences of plasma BDNF, b-NGF, and IGF-1 between responder and non-responder in schizophrenic patientsLee, B. H. / Kim, Y. K. et al. | 2007
- S438
-
P.3.c.025 Drug interactions between aripiprazole and haloperidol: double blind placebo controlled studyShim, J. C. / Jae, Y. M. / Shin, J. G. / Jung, D. W. / Seo, Y. S. / Liu, K. H. / Sohn, J. H. / Kelly, D. L. / Conley, R. R. et al. | 2007
- S439
-
P.3.c.027 Metabolic syndrome and obesity in schizophrenia - influence of antipsychotic drug, smoking and genetic factorsYevtushenko, O. A. / Cooper, S. J. / Docherty, J. K. / ONeill, R. / Woodside, J. V. / Reynolds, G. P. et al. | 2007
- S440
-
P.3.c.029 Effectiveness of switching from risperidone to amisulpride in stabilized schizophrenic patients with depressionKim, S. W. / Yoon, J. S. / Lee, S. H. / Yang, D. S. / Lee, J. H. / Kim, W. J. / Lee, S. Y. / Kim, J. M. / Shin, I. S. / Lee, Y. H. et al. | 2007
- S441
-
P.3.c.030 Psychiatrists attitudes to antipsychotic depots II: changes over the past 5 yearsPatel, M. X. / McLaughlin, S. / Cunningham, P. / David, A. S. / Haddad, P. M. et al. | 2007
- S442
-
P.3.c.032 Was clozapine prescribing delayed?Najim, H. / Heath, D. et al. | 2007
- S443
-
P.3.c.034 Italian Society of Psychiatry (SIP) consensus project on pharmacological treatment of schizophreniaAguglia, E. / Di Giannantonio, M. / Altamura, C. / Ferrannini, L. / Galderisi, S. / Mencacci, C. / Biggio, G. / Pani, L. et al. | 2007
- S444
-
P.3.c.035 Long-term weight gain with clozapine: 8-year cohort naturalistic study among Chinese hospitalized schizophrenic patientsBai, Y. M. / Lin, C. C. / Chen, J. Y. / Lin, C. Y. / Su, T. P. / Chou, P. et al. | 2007
- S445
-
P.3.c.037 Neuropsychological performance and cognitive disability in schizophrenia outpatientsBobes, J. / Garcia-Portilla, M. P. / Fillat, O. et al. | 2007
- S446
-
P.3.c.038 Effects of high doses of amisulpride in psychotic patients not responding to conventional antipsychoticsCastano Asins, J. / Rodriguez Martinez, A. et al. | 2007
- S447
-
P.3.c.040 Antipsychotic effectiveness based on early response in the treatment of schizophreniaKinon, B. / Chen, L. / Ascher-Svanum, H. / Stauffer, V. / Kollack- Walker, S. et al. | 2007
- S448
-
P.3.c.042 Psychopathology and coronary heart disease (CHD) in psychotic patients with and without deficit: the Clamors studyArango, C. / Bobes, J. / Kirkpatrick, B. / Garcia-Garcia, M. / Rejas, J. et al. | 2007
- S449
-
P.3.c.044 Neuroleptic-induced catatonia, neuroleptic malignant syndrome, and extrapyramidal reactionsLee, J. W. et al. | 2007
- S451
-
P.3.c.047 Pharmacokinetics of RGH-188, a new dopamine D3/D2 antagonist/partial agonist atypical antipsychotic, in healthy subjectsPasztor Meszaros, G. / Kapas, M. / Borsos, M. / Laszlovszky, I. / Nemeth, G. / Tihanyi, K. / Szombathelyi, Z. et al. | 2007
- S452
-
P.3.c.049 Association between a 5HT2C receptor haplotype and metabolic abnormalities in patients treated with olanzapineGunes, A. / Melkersson, K. I. / Scordo, M. G. / Dahl, M. L. et al. | 2007
- S453
-
P.3.c.051 Aripiprazole maintenance therapy in bipolar disorder: a placebo-controlled, 74-week extension of a 26-week study (CN138-010)Marcus, R. N. / Keck, P. E. / Calabrese, J. R. / McIntyre, R. S. / Momah, C. / Carson, W. H. / McQuade, R. D. / Carlson, B. X. / Eudicone, J. / Sanchez, R. et al. | 2007
- S455
-
P.3.c.054 Results of a study on psychiatrists perceptions of adherence to medication among patients with schizophrenia: the ADHES surveyTurner, M. / Masand, P. / Roca, M. / Kane, J. et al. | 2007
- S456
-
P.3.c.056 Short-term olanzapine-induced weight gain is not associated with the -2548G/A polymorphism of the leptin geneCiwoniuk, M. / Godlewska, B. R. / Olajossy-Hilkesberger, L. / Olajossy, M. / Marmurowska-Michalowska, H. / Limon, J. / Landowski, J. et al. | 2007
- S458
-
P.3.c.059 Clozapine plasma levels, ABCB1 haplotype and clinical response to treatment in psychotic patientsConsoli, G. / Lastella, M. / Catena, M. / Ciapparelli, A. / Ciofi, L. / Paggini, R. / Golia, F. / DellOsso, L. / Del Tacca, M. / Di Paolo, A. et al. | 2007
- S459
-
P.3.c.061 A review of liver function tests during treatment with a typical antipsychotic drugs: a chart review studyAtasoy, N. / Erdogan, A. / Ozturk, U. / Konuk, N. / Atik, L. / Ustundag, Y. et al. | 2007
- S461
-
P.3.c.064 Pregnancy outcomes of women exposed to mood affecting drugs in Trabzon - TurkeyKadioglu Duman, M. / Muci, E. / Ulku, C. / Yaris, F. / Unsal, M. / Kesim, M. / Kalyoncu, N. / Yaris, E. et al. | 2007
- S462
-
P.3.c.066 Neurocognition and attitudes to medication in risperidone long-acting injectablePenades, R. / Catalan, R. / Pujol, N. / Navarro, V. / Massana, G. / Gasto, C. et al. | 2007
- S463
-
P.3.c.068 Systematic screening for CYP2D6 polymorphisms in the patients with neuroleptic malignant syndromeKato, D. / Kawanishi, C. / Kishida, I. / Furuno, T. / Suzuki, K. / Onishi, H. / Hirayasu, Y. et al. | 2007
- S464
-
P.3.c.070 Factors associated with obesity in schizophrenia: baseline results from the French ESPASS surveyRouillon, F. / Loze, J. Y. / Gasquet, I. / Leguay, D. / Depret- Bixio, L. / Azorin, J. M. et al. | 2007
- S466
-
P.3.c.073 Effects of asenapine on cognitive function in acute schizophrenia: a placebo- and risperidone-controlled trialFleming, K. / Potkin, S. G. / Binneman, B. / Keller, D. / Alphs, L. / Panagides, J. et al. | 2007
- S467
-
P.3.c.075 Risperidone orodispersible tablet and intramuscular haloperidol in treatment of acute psychotic agitationKim, J. J. / Lim, H. K. / Lee, C. U. / Lee, C. / Pae, C. U. / Paik, I. H. et al. | 2007
- S469
-
P.3.c.078 Catechol-O-methyltransferase gene polymorphism in symptomatology of schizophreniaLee, H. / Kweon, Y. et al. | 2007
- S470
-
P.3.c.080 Association between -759C/T and -697G/C polymorphisms of the 5HT2C receptor gene and olanzapine-induced weight gainGodlewska, B. / Olajossy-Hilkesberger, L. / Ciwoniuk, M. / Olajossy, M. / Marmurowska-Michalowska, H. / Limon, J. / Landowski, J. et al. | 2007
- S472
-
P.3.c.083 Metabolic safety of bifeprunox in treatment of acute or stable patients with schizophreniaNewcomer, J. / Sands, E. / Heisterberg, J. / Yeung, P. P. et al. | 2007
- S473
-
P.3.d.001 Aripiprazoles receptor-reserve dependent antagonist properties at human dopamine D2 receptorsTadori, Y. / Kitagawa, H. / Forbes, A. / McQuade, R. / Stark, A. / Kikuchi, T. et al. | 2007
- S474
-
P.3.d.003 Antipsychotic prescription patterns among psychiatrists at state hospital in TurkeyKaramustafalioglu, O. / Ozcelik, B. / Gonenli, S. / Bakim, B. / Ceylan Cengiz, Y. et al. | 2007
- S475
-
P.3.d.004 Sensorimotor gating of the acoustic startle response is improved by morphine in healthy human volunteersQuednow, B. B. / Csomor, P. A. / Chmiel, J. / Beck, T. / Vollenweider, F. X. et al. | 2007
- S476
-
P.3.d.006 Effects of ziprasidone on the stress- induced CRF mRNA expression in the rat hypothalamusKim, Y. H. / Lee, J. G. / Park, S. W. / Choi, S. M. / Lee, S. J. / Kim, N. R. / Lee, C. H. et al. | 2007
- S478
-
P.3.d.009 Effects of SSR103800, a novel GlyT1 inhibitor, on the behavior of NMDA Nr1 hypomorphic mice, a model of schizophreniaBoulay, D. / Pichat, P. / Bergis, O. / Avenet, P. / Griebel, G. et al. | 2007
- S479
-
P.3.d.011 Atypical antipsychotics show late decrease of striatal alpha1 spectral power in the rat electropharmacogramDimpfel, W. et al. | 2007
- S480
-
P.3.d.013 Impact of chronic antipsychotic treatments on hypersensitivity to MK-801 in a neurodevelopmental model of schizophreniaLe Pen, G. / Hazane, F. / Gourevitch, R. / Hoareau, C. / Jay, T. M. / Krebs, M. O. et al. | 2007
- S481
-
P.3.d.015 CYP1A2 polymorphisms and clozapine metabolism in Chinese psychotic patientsChen, J. Y. / Chen, T. T. / Liou, Y. J. / Yen, C. F. / Chang, W. H. et al. | 2007
- S482
-
P.3.d.016 Homer 1 and metabotropic glutamate- receptor 5 polymorphisms are associated with response to treatment in schizophreniaMusil, R. / Spellmann, I. / Zill, P. / Bondy, B. / Douhet, A. / Dehning, S. / Severus, E. / Muller, N. / Moller, H. J. / Riedel, M. et al. | 2007
- S483
-
P.3.d.018 The effects of the antipsychotic drugs on collagen-induced platelet aggregation in vitroDietrich-Muszalska, A. / Rabe-Jablonska, J. / Olas, B. et al. | 2007
- S484
-
P.3.d.020 CAM24, a D3/5HT2a/5HT1a ligand reduces psychostimulant induced hyperactivity in mice without causing motor side effectsSandager-Nielsen, K. / Scheel-Kruger, J. / Fattorusso, C. / Butini, S. / Campiani, G. et al. | 2007
- S486
-
P.3.d.023 In vivo characterization of the effects of asenapine at 5-HT1A, 5-HT2A and a2A-adrenergic receptors in the rat brainGhanbari, R. / El Mansari, M. / Blier, P. et al. | 2007
- S487
-
P.3.e.002 Combined antidepressants and quetiapine therapy in bipolar depression with psychotic features - an open label studyVasile, D. / Vasiliu, O. / Paraschiv, S. / Ojog, D. / Vasile, M. et al. | 2007
- S489
-
P.3.e.005 Anomalies of subjective experience in schizophrenia spectrum disorders: a review of three empirical studiesHandest, P. / Parnas, J. et al. | 2007
- S490
-
P.3.e.007 Specificity of autobiographical memory in a group of stabilized schizophrenic patientsLecompte, D. / Neumann, A. / Nachtergael, H. / Blairy, S. / Philippot, P. et al. | 2007
- S491
-
P.3.e.009 Visual 3 stimulus event-related potential P3a and P3b in passive paradigm in admitted patients with schizophreniaJeon, Y. W. / Park, E. J. / Han, S. I. et al. | 2007
- S492
-
P.3.e.011 Clinical outcome and predictors for the efficacy of electroconvulsive therapy: a retrospective chart reviewChoi, E. Y. et al. | 2007
- S493
-
P.3.e.012 Cabergoline treatment of amisulpride-induced hyperprolactinemiaDi Sciascio, G. / Rampino, A. / Cal`o, S. / Nardini, M. et al. | 2007
- S495
-
P.3.e.016 Hospitalization in schizophrenic patients: influence of antipsychoticGarcia Mahia, M. C. / Castro Calvo, R. / Vidal Millares, M. / Lopez Morinigo, J. D. / Ramos Rios, R. et al. | 2007
- S496
-
P.3.e.018 Two subgroups of schizophrenia identified by robust cognitive neuropsychiatric mappingSzendi, I. / Racsmany, M. / Kovacs, Z. A. / Szekeres, G. / Cimmer, C. / Csifcsak, G. / Galsi, G. / Garab, E. A. / Csefan, G. / Janka, Z. et al. | 2007
- S497
-
P.3.f.002 Effect of the selective glycine re-uptake (GlyT-1) inhibitor Org 25935 on glycine levels in CSF and dialysatesAndrews, N. / Ge, J. / Walker, G. / Schipper, J. / Marston, H. M. et al. | 2007
- S498
-
P.3.f.004 Alterations of the dopamine transporter in lymphocytes of patients with different psychotic disordersMarazziti, D. / Catena, M. / Consoli, G. / Baroni, S. / Picchetti, M. / Giannaccini, G. / Fabbrini, L. / DellOsso, L. et al. | 2007
- S499
-
P.3.f.005 The effect of intraperitoneal MK-801 injection on the mTOR/p70s6k pathway in the rat frontal cortexYoon, S. C. / Seo, M. S. / Kim, S. H. / Jeon, W. J. / Kim, Y. S. et al. | 2007
- S500
-
P.4.a.001 Sleep disorders and obsessive-compulsive disorderDrummond, L. M. / Wulff, K. / Rani, R. S. / Sibanda, J. / Fineberg, N. A. / White, S. / Ghodse, H. et al. | 2007
- S501
-
P.4.a.003 Paroxetine vs. placebo in combination with aerobic exercise or relaxation training in the treatment of panic disorderWedekind, D. / Broocks, A. / Weiss, N. / Rotter-Glattkowski, P. / Engel, K. / Bandelow, B. et al. | 2007
- S503
-
P.4.a.006 Neuropsychological assessment of unmedicated patients with obsessivecompulsive disorder: a controlled trialEbrinc, S. / Semiz, U. B. / Oznur, T. / Basoglu, C. / Iyisoy, M. S. / Algul, A. / Ates, A. / Cetin, M. et al. | 2007
- S504
-
P.4.a.008 Thyroid hormones in panic disorder: possible clinical implicationsPelayo, P. / Herran, A. / Ramirez, M. L. / Sierra-Biddle, D. / Parrila, M. / Hoyuela, F. / Rodriguez, B. / Fernandez, O. / Carrera, M. et al. | 2007
- S505
-
P.4.a.010 Attentional bias for angry, fearful and happy facial expressions in generalized social phobiaGarner, M. / Littler, S. / Mogg, K. / Bradley, B. P. / Baldwin, D. S. et al. | 2007
- S506
-
P.4.a.012 Evaluation of PTSD in a sample of cancer survivors by using PTSD checklist - civilian versionOzdemir, S. / Baser, S. Z. / Kocabasoglu, N. / Papila, C. et al. | 2007
- S507
-
P.4.a.013 Cost of illness of generalized anxiety disorder: a perspective from the primary health-care setting (The ANCORA study)Rovira, J. / Albarracin, G. / Salvador-Carulla, L. / Rejas, J. et al. | 2007
- S508
-
P.4.a.015 Panic-agoraphobic spectrum comorbidity and mitochondrial translocator protein in post-traumatic stress disorderCarmassi, C. / Da Pozzo, E. / Paggini, R. / Ciapparelli, A. / Mundo, F. / Trincavelli, M. L. / Martini, C. / DellOsso, L. et al. | 2007
- S509
-
P.4.a.016 Agomelatine in generalized anxiety disorder: a randomized, placebo-controlled, studyStein, D. J. / Ahokas, A. / Fabiano, A. et al. | 2007
- S510
-
P.4.b.002 Brain biochemistry markers differentiate between animal models of anxiety and depressionMathe, A. A. / Gruber, S. H. / El Khoury, A. / Beiderbeck, D. / Neumann, I. D. / Landgraf, R. et al. | 2007
- S511
-
P.4.b.004 Social anxiety disorder: patterns of incidence and secondary depression riskBeesdo, K. / Bittner, A. / Pine, D. S. / Stein, M. B. / Hofler, M. / Lieb, R. / Wittchen, H. U. et al. | 2007
- S512
-
P.4.b.005 Attenuation of panic-related behaviors after cholecystokinin type 2 receptor antagonism in the rat periaqueductal grayBertoglio, L. J. / De Bortoli, V. C. / Zangrossi Jr., H. et al. | 2007
- S513
-
P.4.b.007 Spontaneous alternation behaviour as an animal model of OCD; the role of dopamine D2 receptors in nucleus accumbensGruca, P. / Litwa, E. / Lason, M. / Papp, M. et al. | 2007
- S514
-
P.4.b.009 Normalization of immune cell imbalance after pharmacological treatments in patients with obsessive-compulsive disorderConsoli, G. / Marazziti, D. / Catena, M. / Masala, I. / Baroni, S. / Ambrogi, F. / Golia, F. / Picchetti, M. / DellOsso, L. et al. | 2007
- S515
-
P.4.b.011 Decrease in serotonin-1A receptor binding correlates with reduced anxiety scores after 12-week SSRI treatmentSpindelegger, C. / Lanzenberger, R. / Mitterhauser, M. / Mien, L. K. / Stein, P. / Wadsak, W. / Moser, U. / Holik, A. / Kletter, K. / Kasper, S. et al. | 2007
- S516
-
P.4.b.012 Chronic diazepam treatment and reactivity of 5-HT1A and 5-HT2A receptors in the dorsal periaqueductal gray matterZangrossi Junior, H. / Bortoli, V. C. / Nogueira, R. L. et al. | 2007
- S517
-
P.4.c.002 Quetiapine augmentation of SSRIs for treatment refractory social anxiety disorderKinrys, G. / Nery, F. / Vasconcelos, D. S. / Rothstein, E. et al. | 2007
- S518
-
P.4.c.004 Relevance of anxiety in emergenciesGines, J. / Espluga, N. / Navines, R. / Corcoles, D. / Garnier, C. / Malagon, M. / Bulbena, A. et al. | 2007
- S519
-
P.4.d.002 Different inhibitory potency of anxiolytics on ultrasonic vocalisation of rats elicited by multiple or single shockingKassai, F. / Gyertyan, I. et al. | 2007
- S520
-
P.4.e.001 The further development of a new model of GAD: II - The effects of single dose anxiolytic medicationBailey, J. E. / Papadopoulos, A. / Rich, A. / Nutt, D. J. et al. | 2007
- S521
-
P.4.e.003 The further development of a new model of GAD: I - the effects of single dose alprazolam and zolpidemPapadopoulos, A. / Bailey, J. E. / Rich, A. / Nutt, D. J. et al. | 2007
- S522
-
P.4.e.005 Determination of Hamilton anxiety rating scale severity gradation in generalized anxiety disorderKott, A. / Friedmann, B. / Miller, D. et al. | 2007
- S523
-
P.4.e.007 Clinical implications of comorbid alcohol use disorder with panic disorder subjectsAhn, J. Y. / Kim, H. S. / Hong, J. P. et al. | 2007
- S524
-
P.4.e.008 Anxiety disorders and the risk for subsequent mood and psychotic disorders in the first three decades of lifeGloster, A. / Beesdo, K. / Hofler, M. / Lieb, R. / Wittchen, H. et al. | 2007
- S525
-
P.4.f.002 Effects of experimentally induced panic attacks on neuroimmunological markersde la Fontaine, L. / Schwarz, M. J. / Eser, D. / Schule, C. / Muller, N. / Rupprecht, R. / Zwanzger, P. et al. | 2007
- S526
-
P.5.a.002 Peg-interferon alpha and ribavirin therapy may induce working memory disturbances in chronic hepatitis C patientsPawelczyk, T. / Pawelczyk, A. / Strzelecki, D. / Bialkowska, J. / Jablkowski, M. / Dworniak, D. / Rabe-Jablonska, J. et al. | 2007
- S527
-
P.5.a.003 Cognitive dysfunctions observed during pegylated interferon alpha and ribavirin therapy may persist after treatment discontinuationPawelczyk, T. / Pawelczyk, A. / Strzelecki, D. / Bialkowska, J. / Jablkowski, M. / Dworniak, D. / Rabe-Jablonska, J. et al. | 2007
- S528
-
P.5.a.005 Specific benefits of memantine on behavioural symptoms in patients with moderate to severe Alzheimers diseaseCummings, J. / Gauthier, S. et al. | 2007
- S529
-
P.5.a.007 How to manage suicidal behaviour in elderlyVucko Miklavcic, I. / Pregelj, P. et al. | 2007
- S530
-
P.5.a.008 Long-acting risperidone in the treatment of institutionalized mentally retarded patientsKouniakis, P. / Tsirogianni, E. / Baltatzi, M. / Sidiropoulos, N. / Hatzitolios, A. / Giouzepas, J. / Fokas, K. et al. | 2007
- S531
-
P.5.a.010 Impact of CYP3A4 polymorphisms on donepezil plasma levels and therapeutic outcomeScordo, M. G. / Villa, L. M. / Miglio, G. / Lombardi, G. / Dahl, M. L. et al. | 2007
- S532
-
P.5.b.002 Cognitive effects of cholinesterase inhibitor rivastigmine on scopolamine-induced amnesia in ratsGetova, D. / Dimitrova, D. et al. | 2007
- S533
-
P.5.b.004 Methylenetetrahydrofolate reductase c.677C>T polymorphism and risk of Alzheimers disease in KoreansKim, J. M. / Kim, S. W. / Yang, S. J. / Shin, I. S. / Lee, S. Y. / Yoon, J. S. et al. | 2007
- S535
-
P.5.c.002 Dementia screening and self-awareness of memory decline in the communityKim, S. / Jeon, H. J. / Cho, M. J. et al. | 2007
- S536
-
P.5.d.002 Increased levels of kynurenic acid may account for neuropsychiatric symptoms in patients with tick-borne encephalitisSchwieler, L. / Mickiene, A. / Holtze, M. / Atlas, A. / Engberg, G. et al. | 2007
- S537
-
P.5.e.001 Carer burden in dementiaSuch, P. / Bjerg, V. / Lestrup, C. / Brady, P. / Jones, E. et al. | 2007
- S538
-
P.6.a.001 The difference of decision-making pattern under ambiguity and risk between alcohol dependence and schizophreniaKim, Y. T. / Kwon, D. H. / Cho, W. / Lee, B. D. / Joe, S. H. / Gim, M. H. / Chae, B. J. et al. | 2007
- S539
-
P.6.a.003 The factors affecting codependence and relationship with how to cope with patient in the family of alcoholicsLee, K. S. / Shin, S. E. / Park, J. E. et al. | 2007
- S540
-
P.6.a.005 Identification of high-risk children of future alcohol usePark, K. / Min, S. / Ahn, J. / Jang, H. / Shin, J. et al. | 2007
- S541
-
P.6.a.006 Problematic drinking behaviors and psychological health in the adolescents of alcoholicsSon, B. K. / Lee, S. K. et al. | 2007
- S542
-
P.6.a.008 Increased plasma brain-derived neurotrophic factor and nerve growth factor in the patients with alcohol dependenceChoi, I. G. / Kim, H. W. / Kim, Y. C. / Han, C. H. / Yang, B. H. / Ham, B. J. / Lee, B. C. et al. | 2007
- S543
-
P.6.a.010 Study of alcohol consumption in ambulatory psychiatric patientsVidal Millares, M. / Espino Diaz, I. / Garcia Mahia, M. C. / Brenlla Garcia, J. et al. | 2007
- S544
-
P.6.a.011 Alcohol use disorder patients in a psychiatric unit: differential traits focussing on psychiatric comorbidityMateu, G. / Castillo, C. / Fonseca, F. / Torrens, M. / Bulbena, A. et al. | 2007
- S545
-
P.6.a.013 Efficacy and tolerability of quetiapine, combined with naltrexone, in the treatment of alcohol dependenceGuardia, J. / Roncero, C. / Galan, J. L. / Barcons, C. / Casas, M. et al. | 2007
- S547
-
P.6.b.002 Peripheral blood alpha-synuclein mRNA levels are elevated in patients with alcoholismTaraskina, A. / Filimonov, V. A. / Kozlovskaya, U. A. / Morozova, M. N. / Smurova, E. L. / Gaschin, D. V. / Schwarzman, A. L. et al. | 2007
- S548
-
P.6.b.004 Effects of clozapine on ethanol withdrawal syndrome in ratsKayir, H. / Uzbay, I. T. et al. | 2007
- S549
-
P.6.c.001 Aripiprazole and addictive properties of opioids painkillers in cancer patients with chronic painSushko, V. et al. | 2007
- S550
-
P.6.c.003 Aripirazole for methamphetamine dependence; a phase I human safety studyElkashef, A. / Newton, T. / De la Garza, R. / Reid, M. / Mojsiak, J. et al. | 2007
- S552
-
P.6.d.002 Effects of cannabis use on associative memory in adolescents, and the role of personality measures: an fMRI studyLuijten, M. / Jager, G. / Block, R. I. / Zuccarelli, J. M. / Becker, M. M. / Ramsey, N. F. et al. | 2007
- S553
-
P.6.d.004 Regulation of the apoptotic machinery in the prefrontal cortex of human opioid abusersGarcia-Sevilla, J. A. / Garcia-Fuster, M. J. / Davidson, A. / Rivero, G. / LaHarpe, R. / Meana, J. J. et al. | 2007
- S555
-
P.6.d.007 The selective nicotinic alpha7 receptor agonist SSR180711 does not induce locomotor sensitisationMirza, N. / Troelsen, K. B. / Taouli, L. S. et al. | 2007
- S556
-
P.6.d.009 A novel approach to assess drug-induced aversion to ethanolDravolina, O. / Sukhotina, I. / Zvartau, E. / Bespalov, A. et al. | 2007
- S557
-
P.6.d.011 Effects of prolonged nicotine exposure and withdrawal on a differential-reinforcement-of- low-rate performance in ratsSukhotina, I. / Malyshkin, A. / Zvartau, E. / Bespalov, A. et al. | 2007
- S559
-
P.6.e.003 Internet addiction and its social consequencesKwiatkowska, A. / Ziolko, E. / Krysta, K. / Muc-Wierzgon, M. / Brodziak, A. / Krupka-Matuszczyk, I. / Przybylo, J. et al. | 2007
- S560
-
P.6.e.005 Relationship between personality dimensions, substance misuse and repetition of deliberate self harmSinclair, J. / Garner, M. J. / Baldwin, D. S. et al. | 2007
- S561
-
P.6.e.007 Effect of nicotine patches on craving in a workplace smoking cessation programChoi, K. S. / Lee, C. H. / Kim, S. Y. / Choi, T. S. / Ryu, S. H. et al. | 2007
- S563
-
P.6.e.010 Who are incoming cocaine consuming patients in a drug addiction centre in Milan in 2006?Zita, G. / Artale, L. / Vivirito, M. / Burato, A. / Di Cosmo, F. / Vigezzi, P. / Cozzolino, E. et al. | 2007
- S564
-
P.6.f.002 Duloxetine in depressed patients with comorbid substance abuseBatlle, E. / Fernandez, T. / Giron`es, V. / Martinez, J. / Rivas, I. / Romero, C. et al. | 2007
- S565
-
P.6.f.004 Temperament differences between early and late onset Korean male pathologic gamblersShin, Y. C. / Kim, J. G. / Lim, W. J. / Lim, S. W. / Lee, M. S. / Oh, K. S. / Choi, S. W. et al. | 2007
- S566
-
P.6.f.005 Platelet 5-HT transporter in pathological gamblersGolia, F. / Marazziti, D. / Baroni, S. / Picchetti, M. / Lenzi, F. / Consoli, G. / Carlini, M. / Baldini, A. / Giannaccini, G. / DellOsso, L. et al. | 2007
- S567
-
P.7.a.002 Adolescent attention deficit/hyperactivity disorder (ADHD) treatment with controlled- release methylphenidateOh, E. / Yoo, J. H. et al. | 2007
- S568
-
P.7.a.004 The extent of pupillary fluctuations in the dark correlates with anxiety, depressive and autistic symptoms in ADHDSzabo, K. / Nagyova, K. / Szele, Z. / Vetro, A. / Tokaji, Z. et al. | 2007
- S570
-
P.7.b.003 Autoantibodies directed against melanocortin peptides are associated with feeding and anxiety in ratsFetissov, S. / Hamze Sinno, M. / Do Rego, J. C. / Coeffier, M. / Bole-Feysot, C. / Hokfelt, T. / Costentin, J. / Ducrotte, P. / Dechelotte, P. et al. | 2007
- S571
-
P.7.c.001 Multi-center study for evaluation of efficacy and safety of methylphenidate-OROS in children with ADHDLee, J. H. / Jung, C. H. / Song, C. J. / Choi, S. Y. / Jeong, S. H. / Chung, U. S. / Seo, W. S. / Lee, K. H. et al. | 2007
- S572
-
P.7.c.002 The effects of aripiprazole in chronic tic symptoms and executive functionsSung, H. M. / Sea, H. S. / Seo, W. S. / Lee, J. S. et al. | 2007
- S573
-
P.7.c.004 Valproate in the treatment of acute mania in adolescents with bipolar disorderAzorin, J. M. et al. | 2007
- S574
-
P.7.c.006 Methylphenidate-induced stabilization of the sympathetic/parasympathetic tone in children with ADHDNagyova, K. / Szabo, K. / Vetro, A. / Tokaji, Z. et al. | 2007
- S576
-
P.7.d.002 Longitudinal study of neurotrophic factors in children and adolescents with a first psychotic episodeDel Moral, E. / Palomino, A. / Matute, C. / Palomo, J. / Alvarez de Eulate, S. / Iruin, A. / Gonzalez-Pinto, A. et al. | 2007
- S577
-
P.7.e.001 Study about temperament, family environment, and development of Korean childrenSon, J. / Lee, S. / Kim, S. / Shin, C. / Hong, S. / Choi, S. et al. | 2007
- S579
-
P.7.e.004 Prefrontal cortex N-acetyl-aspartate in early-onset psychosis: cognitive correlates, course and predictive valueZabala, A. / Sanchez, J. / Parellada, M. J. / Robles, O. / Burdalo, M. / Moreno, D. / Ruiz Sancho, A. / Mayoral, M. / Desco, M. / Arango, C. et al. | 2007
- S580
-
P.8.a.002 Searching for variables associated with familial suicide attempts using data mining techniquesSaiz Gonzalez, D. / Baca-Garcia Enrique, E. / Perez Rodriguez, M. / Basurte Villamor, I. / Saiz-Ruiz, J. / Leiva- Murillo, J. M. / Prado-Cumplido, M. / Santiago Mozos, R. / Artes Rodriguez, A. / de Leon, J. et al. | 2007
- S581
-
P.8.a.004 Comparison of hypnotic drug use in older people with depression, dementia and schizophreniaCurran, S. / Turner, D. / Musa, S. / Byrne, A. / Wattis, J. P. et al. | 2007
- S582
-
P.8.a.005 Plasma amino acids and neopterin in healthy subjects with Downs syndromeVerhoeven, W. M. / Coppus, A. M. / Fekkes, D. / Tuinier, S. / Egger, J. I. / Van Duijn, C. M. et al. | 2007
- S583
-
P.8.a.007 Quetiapine reduces impulsivity and affective symptoms in borderline personality disorderVan den Eynde, F. / Senturk, V. / Vogels, C. / van Heeringen, C. / Audenaert, K. et al. | 2007
- S584
-
P.8.a.009 Malondialdehyde as a biological marker of acute schizophreniaDiaz-Mesa, E. / Morera, A. / Abreu, P. / Henry, M. / Intxausti, A. / Hernandez-Garcia, D. / Orozco-Sanmartin, A. / Garcia-Valdecasas-Campelo, J. / Gracia, R. et al. | 2007
- S586
-
P.8.a.012 Effect of caffeine on ethanols sedative and performance-disruptive effectsLee, S. W. / Kim, J. L. / Yu, N. J. / Chee, I. S. et al. | 2007
- S587
-
P.8.a.014 Absence of circadian and seasonal rhythms of total antioxidant status in healthy subjectsMorera, A. / Abreu, P. / Henry, M. / Garcia-Hernandez, A. / Guillen-Pino, F. / Orozco, A. / Intxausti, A. / Diaz-Mesa, E. / De la Varga, M. / Gracia, R. et al. | 2007
- S589
-
P.8.a.017 The effects of modafinil on driving and self-assessment of driving performance during sleep deprivationGurtman, C. / Broadbear, J. / Redman, J. et al. | 2007
- S590
-
P.8.a.019 Designing a profile of suicide attempter in the National Institute of Mental Health, Lima - Peru, 2006Vasquez, F. / Mitrani, M. / Nicolas, Y. / Falconi, S. / Vite, V. et al. | 2007
- S591
-
P.8.a.021 A new instrument to measure ICF based efficacy in psychopharmacology: the Mini-ICF-PLinden, M. et al. | 2007
- S593
-
P.8.a.024 Pregabalin in patients with antidepressant treatment-resistant somatoform disorders: a case seriesStrohle*, A. / Harnack, D. / Scheel, M. / Mundt, A. / Heinz, A. et al. | 2007
- S595
-
C.01.03 Implications of sustained effectiveness in managing schizophreniaCanas, F. et al. | 2007
- S596
-
C.02.02 The role of the reproductive hormones in mood disordersBlier, P. et al. | 2007
- S599
-
C.05.01 Implications of circadian rhythms for human health and well-being: causes and consequences of disruptionsFrank, E. et al. | 2007
- S600
-
C.05.04 Targeting the melatonergic system: a new approach to treat depressionHamon, M. et al. | 2007
- S601
-
C.06.03 Switch and augmentation strategies in antipsychotic treatment: What can we learn from trials and patient cases?Nielsen, J. et al. | 2007
- S603
-
C.09.04 Impact of appropriate treatment on patients livesMasand, P. / Buckley, P. / Conley, R. / Kasper, S. et al. | 2007
- S604
-
C.10.03 Pharmacology of behavioural effects of MemantineFrancis, P. et al. | 2007
- S605
-
C.12.04 A high quality remission: benefits for depressed patientsLam, R. et al. | 2007
- S606
-
C.14.03 Recognizing and treating attention- deficit/hyperactivity disorder in adults: short- and long-term treatment outcomesSpencer, T. et al. | 2007
- S607
-
C.15.03 Bipolar disorder: optimal management strategiesBowden, C. L. et al. | 2007
- S611
-
C.20.04 Anxiety disorders treated with an ASRI antidepressantBaldwin, D. S. et al. | 2007
- S613
-
Author Index| 2007
- S631
-
Keyword Index| 2007
- v
-
Foreword: Improved understanding and treatment of schizophreniaLappin, J. M. / Di Forti, M. / Murray, R. M. et al. | 2007
-
S.01.04 Psychopharmacological treatment of autism and its comorbid disordersCroonenberghs, J. / Deboutte, D. et al. | 2007
-
S.02.02 Augmentation and dose response strategiesBech, P. et al. | 2007
-
S.02.03 Suicide in depression: is this the consequence of treatment resistance?Rihmer, Z. et al. | 2007
-
S.08.01 Innovative technologies to investigate nitric oxide in brain and in vivo: the example of the sleep-wake cycle pathwaysCespuglio, R. / Rousset, C. / Lefebvre-Descamps, A. et al. | 2007
-
S.07.03 I.V. citalopram vs I.V. clomipramine in partial/non-responder depressed patients: a randomized, single-blind studyZanoni, S. / DellOsso, B. / Buoli, M. / Mundo, E. / Bosi, M. F. / Altamura, A. C. et al. | 2007
-
S.15.03 Combined effect of antidepressant and anti-inflammatory drugs in an animal model of depressionBrunello, N. / Alboni, S. / Benatti, C. / Corsini, D. / Capone, G. / Tascedda, F. / Mendlewicz, J. et al. | 2007
-
S.16.01 Role of ERK signalling activation in the actions of drugs of abuseHerve, D. / Valjent, E. / Caboche, J. / Girault, J. A. et al. | 2007
-
S.28.04 Endogenous kynurenate regulates dopaminergic activity: implications for schizophrenia researchErhardt, S. / Schwieler, L. / Nilsson, L. K. / Andersson, L. A. / Linderholm, K. R. / Holtze, M. / Olsson, E. / Olsson, S. K. / Engberg, G. et al. | 2007
-
P.1.b.001 Association of NOS1 and NOS3 variants with the serotonergic marker loudness dependence of auditory evoked potentialsKawohl, W. / Giegling, I. / Mavrogiorgou, P. / Pogarell, O. / Mulert, C. / Hegerl, U. / Rujescu, D. / Juckel, G. et al. | 2007
-
P.1.c.002 Multiple sclerosis long-term remission after a high dose of cyclophosphamideKountouris, D. / Koutsobelis, K. / Karachristou, K. / Bougioukou, A. et al. | 2007
-
P.1.c.004 Hyperalgesic effect of escitalopram in two animal models of acute painSuciu, R. / Ardelean, M. et al. | 2007
-
P.1.c.009 Memory impairment induced by chronic sodium fluoride intakeAndreatini, R. / Chioca, L. R. / Rauppp, I. M. / Da Cunha, C. / Losso, E. M. et al. | 2007
-
P.1.c.018 Novel neuronal nicotinic receptor selective compounds for the treatment of acute, chronic and neuropathic painLippiello, P. M. / Gatto, G. J. / Jordan, K. G. / Bencherif, M. et al. | 2007
-
P.1.c.020 Transmitter specific drug profiling using electropharmacograms from freely moving rats: dopamine, serotonin and GABADimpfel, W. et al. | 2007
-
P.1.e.012 Assessment of serotonin release capacity in the human brain using dexfenfluramine challenge and [18F]altanserin-PETHasler, F. / Quednow, B. B. / Treyer, V. / Wyss, M. T. / Ametamey, S. M. / Vollenweider, F. X. et al. | 2007
-
P.2.a.020 Cortisol, CD19 and CD56 cell levels in patients with major depressive disorderJeon, Y. W. / Park, E. J. / Han, S. I. et al. | 2007
-
P.2.b.006 The influence of L-tryptophan on anxiety behavior in young and old rats with imbalance of thyroid hormonesMasalova, O. / Fedotova, J. O. et al. | 2007
-
P.2.b.013 A comparison of the pharmacokinetics of venlafaxine extended release and desvenlafaxine succinate in healthy subjectsPreskorn, S. / Patroneva, A. / Nichols, A. / Silman, H. / Pedersen, R. / Paul, J. / Ahmed, S. et al. | 2007
-
P.2.c.020 The impact of treatment on quality of life in major depressive disorder and generalized anxiety disorderDemyttenaere, K. et al. | 2007
-
P.2.d.015 The effects of desvenlafaxine succinate and paroxetine on the pharmacokinetics of desipiramine in healthy adultsPatroneva, A. / Nichols, A. I. / Fatato, P. / Shenouda, M. / Paul, J. / Pedersen, R. D. / Jiang, Q. / Ahmed, S. et al. | 2007